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ABSTRACT
The characteristics of drug addiction include compulsive drug use despite negative 
consequences and re-occurring relapses, returns to drug use after a period of abstinence. 
Therefore, relapse prevention is one of the major challenges for the treatment of drug 
addiction. There are three main factors capable of inducing craving for drugs and 
triggering relapse long after cessation of drug use and dissipation of physical withdrawal 
signs: stress, re-exposure to the drug, and environmental stimuli (cues) that have been 
previously associated with drug use.  
The neurotransmitters dopamine and glutamate have been implicated in the modulation of 
drug-seeking behavior. The aim of this project was to examine the role of glutamatergic 
neurotransmission in relapse triggered by conditioned drug-associated stimuli. The focus 
was on clarifying whether relapse to drug seeking can be attenuated by blockade of 
glutamate receptors. In addition, as the nucleus accumbens has been proposed to 
participate in the modulation of drug-seeking behavior, the effects of glutamate receptor 
blockade in this brain structure on cue-induced relapse were investigated. 
The studies employed animals models in which rats were trained to press a lever in a test 
cage to obtain alcohol or intravenous cocaine. Drug availability was paired with distinct 
olfactory, auditory, or visual stimuli. This phase was followed by extinction training, 
during which lever presses did not result in the presentation of the drug or the drug-
associated stimuli. Extinction training led to a gradual decrease in the number of lever 
presses during test sessions. Relapse was triggered by presenting the rats with the drug-
associated stimuli in the absence of alcohol or cocaine. The drug-associated stimuli were 
alone capable of inducing resumption of lever pressing and maintaining this behavior 
during repeated testing. The number of lever presses during a session represented the 
intensity of drug-seeking and relapse behavior. 
The results suggest that glutamatergic neurotransmission is involved in the modulation 
of drug-seeking behavior. Both alcohol and cocaine relapse were attenuated by 
systemic pretreatment with glutamate receptor antagonists. However, differences were 
found in the ability of ionotropic AMPA/kainate and NMDA receptor antagonists to 
regulate drug-seeking behavior. The AMPA/kainate antagonists CNQX and NBQX, and 
L-701,324, an antagonist with affinity for the glycine site of the NMDA receptor, 
attenuated cue-induced drug seeking, whereas the competitive NMDA antagonist 
CGP39551 and the NMDA channel blocker MK-801 were without effect.  MPEP, an 
antagonist at metabotropic mGlu5 glutamate receptors, also decreased drug seeking, but 
its administration was found to lead to conditioned suppression of behavior during 
subsequent treatment sessions, suggesting that MPEP may have undesirable side effects. 
The mGluR2/3 agonist LY379268 and the mGluR8 agonist (S)-3,4-DCPG decreased 
both cue-induced relapse to alcohol drinking and alcohol consumption. Control 
experiments showed however that administration of the agonists was accompanied by 
motor suppression limiting their usefulness.  
Administration of the AMPA/kainate antagonist CNQX, the NMDA antagonist D-AP5, 
and the mGluR5 antagonist MPEP into the nucleus accumbens resulted also in a 
decrease in drug-seeking behavior, suggesting that the nucleus accumbens is at least one 
of the anatomical sites regulating drug seeking and mediating the effects of glutamate 
receptor antagonists on this behavior. 
Keywords: relapse, drug seeking, glutamate, cues, alcohol, cocaine, rats 
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TIIVISTELMÄ 
Alkoholi- ja huumeriippuvuudelle on tyypillistä pakonomainen tarve käyttää päihdettä ja 
toistuvat retkahtamiset raittiiden kausien jälkeen. Stressi, päihteelle altistuminen ja 
päihteen käyttöön liittyneet ehdollistuneet ärsykkeet voivat aiheuttaa voimakkaan ja 
hallitsemattoman päihteen himon ja retkahtamisen kauankin päihteen käytön ja fyysisten 
vieroitusoireiden loputtua. Näin ollen tehokas päihderiippuvuuden hoito edellyttää paitsi 
päihteiden akuuttien vaikutusmekanismien selvittämistä myös retkahtamisen neuro-
biologian tuntemista. 
Dopamiini ja glutamaatti ovat pääasialliset päihdehakuista käyttäytymistä säätelevät 
hermovälittäjäaineet. Tämän tutkimuksen tarkoituksena oli selvittää glutamatergisen 
hermovälityksen merkitystä aistiärsykkeiden laukaisemassa retkahtamisessa. Erityisesti 
pyrittiin selvittämään, voidaanko retkahtamisalttiutta vähentää glutamaattireseptoreiden 
salpauksella. Lisäksi tutkittiin retkahtamiskäyttäytymisen kannalta tärkeänä pidetyn 
accumbens-aivotumakkeen merkitystä aistiärsykkeiden laukaisemassa päihdehakuisessa 
käyttäytymisessä. 
Tutkimuksissa käytettiin koe-eläinmalleja, joissa rotat opetettiin annostelemaan itselleen 
alkoholia tai kokaiinia koehäkissä olevaa vipua painamalla. Päihteiden saatavuuteen 
yhdistettiin valo-, ääni- tai tuoksuärsykkeitä. Opetusta seuranneen ekstinktiovaiheen 
aikana päihdettä ei ollut saatavilla eikä koehäkissä ollut aistiärsykkeitä. Tällöin vivun 
painaminen vähitellen lakkasi palkinnon puuttuessa. Retkahtaminen laukaistiin 
altistamalla rotat päihteiden vaikutuksiin yhdistyneille aistiärsykkeille. Tällöin vivun 
painaminen alkoi uudelleen, vaikka alkoholia tai kokaiinia ei ollut testitilanteessa 
saatavilla. Vivunpainallusten määrä retkahtamistestissä mittasi retkahtamisalttiutta ja 
päihdehakuisuutta. 
Tulokset osoittavat, että glutamaterginen hermovälitys säätelee päihdehakuista 
käyttäytymistä. Sekä alkoholi- että kokaiiniretkahtamista voitiin vähentää systeemisesti 
annostelluilla glutamaattireseptoriantagonisteilla. Ionotrooppisten glutamaattiantago-
nistien vaikutus riippui kuitenkin reseptorityypistä sekä sitoutumiskohdasta reseptorissa. 
AMPA/kainaattiantagonistit CNQX ja NBQX sekä NMDA-reseptorin glysiinikohtaan 
sitoutuva antagonisti L-701,324 vähensivät retkahtamista. Sen sijaan kompetitiivisella 
NMDA-antagonisti CGP39551:llä ja NMDA-reseptorin kanavasalpaaja MK-801:llä ei 
ollut vaikutusta retkahtamisalttiuteen. mGluR5-tyypin metabotrooppinen glutamaatti-
reseptoriantagonisti MPEP vähensi päihdehakuista käyttäytymistä, mutta lääkeaineen 
annostelulla oli myös ehdollistuneita, rottien vivunpainamista alentavia pitkäaikais-
vaikutuksia. mGluR2/3-agonisti LY379268 ja mGluR8-agonisti (S)-3,4-DCPG vähensivät 
sekä alkoholin juomista että aistiärsykkeiden laukaisemaa retkahtamista, mutta molemmat 
agonistit heikensivät myös motorista suorituskykyä. Ei-toivotut sivuvaikutukset tulevat 
todennäköisesti estämään lääkeaineiden hyötykäytön. 
AMPA/kainaattiantagonisti CNQX, NMDA-antagonisti D-AP5 ja mGluR5-antagonisti 
MPEP vähensivät kokaiiniretkahtamista myös aivojen accumbens-tumakkeeseen 
annosteltuna. Tämä viittaa siihen, että accumbens-tumake on yksi aivoalueista, joiden 
kautta glutamaattireseptoriantagonistien retkahtamista hillitsevät vaikutukset välittyvät. 
Avainsanat: retkahtaminen, päihteet, glutamaatti, alkoholi, kokaiini, rotta 
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ABBREVIATIONS 
ADE alcohol deprivation effect 
AGS3 activator of G protein signaling 3 
AMPA ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ANOVA analysis of variance 
ATP adenosine triphosphate 
cAMP cyclic adenosine monophosphate 
CGP39551  DL-(E)-2-amino-4-methyl-5-phosphono-3-pentanoic acid  
 carboxyethylester 
CNQX 6-cyano-7-nitroquinoxaline-2,3-dione disodium 
CRF corticotropin-releasing factor 
CS+/- conditioned (discrete) stimulus 
D-AP5 D-(-)-2-Amino-5-phosphonopentanoic acid   
DRL differential reinforcement of low rates of responding 
FI fixed interval 
FR fixed ratio 
GABA ?-aminobutyric acid 
ip intraperitoneally 
iv intravenously 
LAAM L-?-acetylmethadol 
LY37926 (-)-2-oxa-4-aminobicyclo hexane-4,6-dicarboxylic acid 
mGlu metabotropic glutamate 
MK-801 (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine 
hydrogen maleate 
MPEP 2-Methyl-6-(phenylethynyl)pyridine hydrochloride 
NBQX 2,3-Dioxo-6-nitro-1,2,3,4-tetra-hydrobenzo[f]quinoxaline-7- 
 sulfonamide 
NMDA N-methyl-D-aspartate 
(S)-3,4-DCPG (S)-3,4-dicarboxyphenylglycine 
S stimulus (in reinforcement schedules) 
S+/- discriminative stimulus 
w/v weight/volume 
v/v volume/volume 
VI variable interval 
VR variable ratio 
VTA ventral tegmental area 
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1 INTRODUCTION
The characteristics of drug addiction include impaired ability to control drug taking, 
compulsive drug use, continued use despite obvious psychological and social harm, and 
drug craving (O'Brien and Gardner, 2005). Addiction is also characterized by relapses, 
returns to drug use after a period of abstinence. Stress, re-exposure to drugs, and drug-
associated environmental stimuli have been shown to trigger craving in abstinent drug 
and alcohol users, but also in non-addicted social drinkers (Cooney et al., 1997; de Wit 
and Chutuape, 1993; Greeley et al., 1993). The susceptibility to relapse can be predicted 
by the intensity of craving (Cooney et al., 1997; but see Tiffany and Carter, 1998). 
Drugs that are abused by humans are in most cases also self-administered by 
experimental animals. However, it is likely that the mechanisms that mediate the acute 
effects of drugs differ from those controlling drug-seeking and relapse behavior. As the 
subjective feeling of craving is difficult to measure in laboratory animals, several 
experimental paradigms modeling different aspects of relapse and drug-seeking behavior 
have been developed (Markou et al., 1993). These models concentrate on measuring the 
motivation of the animal to obtain drugs. 
Evidence from animal experiments suggests that dopamine, which is clearly involved in 
the acute reinforcing effects of most drugs of abuse, modulates also drug-seeking 
behavior. In addition, glutamate and several other transmitter have been found to be 
involved. It seems that drugs, drug-associated cues, and, to a lesser extent, stress are all 
capable of activating dopaminergic and glutamatergic neurotransmission which leads to 
an increased probability of relapse.  
So far, there are few effective pharmacological treatments for drug and alcohol addiction 
(Heidbreder, 2005). Successful pharmacological relapse prevention requires insight into 
the neurobiology of the phenomenon. Therefore, the present experiments were designed 
to specifically examine the involvement of different glutamate receptor subtypes in 
modulation of drug-seeking behavior induced by drug-associated cues. The hypothesis 
was that cue-induced drug seeking can be decreased by counteracting the effects of cue-
induced glutamate release by (presumably) postsynaptically acting glutamate receptor 
antagonists or by decreasing glutamate release by presynaptic modulation. To better 
assess the extent to which glutamate receptor antagonists and agonists are able to 
modulate drug seeking, experiments were conducted with both alcohol and the 
psychostimulant cocaine. 
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2 REVIEW OF THE LITERATURE 
2.1 Addiction and relapse 
Relapse, return to drug use after a period of abstinence, is one of the major challenges in 
the treatment of drug and alcohol addiction. Escape from physical withdrawal symptoms 
that emerge following discontinuation of drug use can sometimes be a factor leading to 
relapse. However, there are several drugs of abuse, such as cocaine and amphetamine, 
that do not produce severe somatic withdrawal signs (Lago and Kosten, 1994). Despite 
this, abusers of these drugs frequently relapse. Relapse can also, and often does, occur 
long after the signs of physical withdrawal have dissipated (Hyman, 2005). This 
indicates that drug seeking and subsequent relapse are induced by other processes than 
physical discomfort during withdrawal. 
Initially, drug taking is driven by the acute reinforcing effects of the drug. With prolonged 
drug use, additional factors start regulating drug seeking and taking. One consequence of 
repeated drug taking is an adaptation to the presence of the drug and a change in the 
functioning of the brain (Tzschentke and Schmidt, 2003). Thus, stopping drug use upsets 
the balance of brain systems, which can manifest itself as physiological and psychological 
withdrawal signs. Repeated use of drugs also leads to the association of different discrete 
and environmental cues with the act of drug taking and the effects of the drug. These cues 
can acquire conditioned reinforcing properties of their own and later on trigger craving and 
drug-seeking behavior in the absence of the drug (Di Ciano and Everitt, 2004; Grüsser et 
al., 2004; See, 2005). It has been proposed that in an addicted person, drug-associated cues 
acquire more and more significance while natural reinforcers start to be ignored. As a 
result, behavior becomes pathologically oriented towards drug-associated stimuli and drug 
seeking at the expense of other behaviors (Hyman, 2005). 
In addition to drug-associated cues, negative mood and re-exposure to the drug can 
trigger relapse (Self, 1998). Studies in abstinent alcohol and drug users have shown that 
all of these factors – cues, stress, and re-exposure to the drug – increase the urge and 
probability of consuming drugs or alcohol. Presentation of an alcoholic beverage to 
abstinent alcoholics (Cooney et al., 1997) or the smell of alcohol alone (Schneider et al., 
2001) increases subjective ratings of craving and desire to drink, as does negative mood 
(Cooney et al., 1997). In subjects with a history of cocaine use, videos showing the drug 
taking act, imagery of autobiographical memories of drug use, or other cocaine-related 
cues increase self-reported cocaine craving (Ehrman et al., 1992; Foltin and Haney, 
2000; Kilts et al., 2001; Kilts et al., 2004).  In addition to subjective feelings of craving, 
drug-associated cues can lead to changes in physiological measures such as skin 
resistance, temperature, and heart rate (Ehrman et al., 1992). 
Brain imaging studies have shown that drug imagery or the presentation of drug-
associated cues to abstinent drug users leads also to activation of brain areas including 
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the prefrontal cortex, nucleus accumbens, and amygdala (Kilts et al., 2001; Schneider et 
al., 2001). Activation of these brain regions has been found to correlate with the 
probability of future relapse (Kosten et al., 2006), showing that craving and relapse have 
a neuroanatomical basis.  
As a result of repeated and prolonged drug use the mechanisms mediating craving and 
relapse behavior probably differ from those mediating the acute reinforcing effects of 
drugs. Therefore, understanding the neurobiology of relapse is essential for the 
development of new pharmacological treatments for drug addiction. 
2.2 Animal models of drug seeking 
Many aspects of drug and alcohol addiction can be modelled and studied in laboratory 
animals. Animal experiments allow studies that for ethical reasons cannot be conducted in 
human drug addicts. Also, in animal studies the background of the subjects can be strictly 
controlled. In human subjects this is often a difficult task, as polydrug use is common among 
addicts, and so are differences in mental, nutritional and socioeconomic status. There is 
consistency among the findings from animal experiments and clinical trials. For example, 
buprenorphine and L-?-acetylmethadol (LAAM), which are used as opioid replacement 
pharmacotherapy, decrease opiate use in laboratory animals (Grabowski et al., 2004). The 
suppressive effects on alcohol drinking by naltrexone that is used in the treatment of 
alcoholism were also discovered in animal studies (O'Brien and Gardner, 2005).  
Behavioral animal models of addiction often involve measures of drug taking, drug 
seeking, or evaluation of the reinforcement obtained from the drug. The term positive 
reinforcement is sometimes used to describe reward, but, by definition, a positive 
reinforcer is a stimulus that increases the frequency of behavior that leads to its 
presentation (Stolerman, 1992). ‘Reward’ implies a hedonic or positive affective state, 
i.e. suggests pleasure, whereas reinforcement is not necessarily perceived as pleasurable, 
or perceived at all. A negative reinforcer, correspondingly, increases the frequency of 
behavior that prevents or terminates its presentation (Stolerman, 1992). For example, a 
laboratory rat may be willing to perform a task if this results in the delivery of a positive 
reinforcer (such as a sucrose pellet) but also to perform a task if this prevents a negative 
reinforcer (e.g. electric shock) from being delivered. In other words, a positive reinforcer 
reinforces when it is presented and a negative reinforcer reinforces when it is withdrawn. 
2.2.1 Operant models 
Animals can be trained to perform an operant task, e.g. press a lever, in a test cage to 
obtain a reinforcer. The cages are called operant chambers or Skinner boxes after B.F. 
Skinner, the discoverer of operant behavior (see www.bfskinner.org). Animals are either 
living in the operant chambers or transferred to them for the duration of a test session. 
The chamber typically contains a manipulandum, often a lever, turning wheel, or nose-
poke hole that the animal can “operate” to control the delivery of the reinforcer. An 
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inactive manipulandum is usually present to provide better measurement of response 
specificity. If a stimulus is reinforcing, the animal should respond significantly more on 
the active manipulandum. In addition, the chamber can contain lights, loudspeakers etc. 
for delivering visual or auditory stimuli during the session or the chamber may be 
equipped to deliver food pellets to a food tray or small electrical currents, foot shocks, 
through the floor. A computer is used to control the contingencies of the sessions and 
record the response data of the animals. 
The task that the animal is required to perform in the chamber can be chosen so that it 
allows the measurement of different aspects of behaviour. Operant chambers can be used 
to measure drug or food reinforcement (i.e. drug/food taking, self-administration), drug 
seeking, relapse, or to compare the subjective effects of drugs. In addition, the effects of 
different manipulations on these behaviours, once established, can be examined. 
M o d e l s  o f  d r u g  t a k i n g  
One of the simplest operant tasks, or schedules of reinforcement, is the continuous 
reinforcement or fixed ratio 1 (abbreviated FR1) schedule. Under this schedule, every 
operant response (e.g. lever press) on the active manipulandum is reinforced, usually 
with a drug dose or food pellet. Increasing the number of responses required for 
reinforcement delivery allows better measurement of the selectivity and motivation of 
responding. Therefore, schedules such as FR5, under which five responses are required 
for reinforcement delivery, are frequently used.  
The progressive ratio schedule measures especially well the motivation to obtain the 
reinforcer. Under these schedules, very few responses are required for the delivery of the 
first reinforcer, but for each subsequent reinforcer the response requirement is increased 
(sometimes even doubled) according to a predetermined schedule (Richardson and 
Roberts, 1996; Stafford et al., 1998). A session is considered completed when the animal 
fails to receive a reinforcer within a specified time period, often one hour. The final 
response ratio reached is called the breaking point and represents the maximal effort the 
animal is willing to make to receive the reinforcer. The motivation to obtain the 
reinforcer (drug) is considered higher with higher breaking points. 
Self-administration schedules can be complicated further. To mention a few examples, 
under variable ratio (VR) schedules the number of responses per reinforcer is varied, 
resulting in very high rates of responding. Differential reinforcement of low rates of 
responding (DRL) schedules result in very low response rates as a response is reinforced 
only if it is performed following a defined period of non-responding. Premature responses 
“reset the clock” and are not rewarded (Monterosso and Ainslie, 1999). DRL schedules can 
be used to measure impulsivity of behavior. Under interval schedules the first response 
after a defined period of time is reinforced, but premature responding does not lead to 
punishment or postponement of the reinforcer. Variable interval (VI) schedules take his 
further by varying the time to the reinforced response. Both of these interval schedules 
usually lead to a scalloped pattern of responding when the animal first responds very little 
or not at all, but increases its response rates towards the end of the interval. 
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S e c o n d - o r d e r  s c h e d u l e s  
Second-order schedules are often used to incorporate stimulus presentations (e.g. light or 
tone presentations) into the schedule (Schindler et al., 2002). During repeated training 
sessions, these stimuli acquire conditioned reinforcing properties and the ability to 
control behavior on their own. The conditioned reinforcing properties of the stimuli can 
be demonstrated by experiments in which they support learning of a new response that 
leads to their presentation (Di Ciano and Everitt, 2004). 
Second-order schedules contain two components, usually a fixed ratio schedule and a 
fixed-interval schedule or two fixed ratio schedules. For example, under the second-
order schedule FR4(FR5:S) the animal is required to press a lever (or perform some 
other response such as nose-poke) five times to receive a stimulus presentation (FR5:S 
component). Simultaneously with the fourth stimulus presentation, the animal receives 
the reinforcer (FR4 component). Under a FI15min(FR5:S) schedule every fifth response 
leads to a stimulus presentation, and the first stimulus presentation after fifteen minutes 
has elapsed leads to reinforcer delivery. 
Fixed-interval second-order schedules of self-administration are usually employed to 
measure drug seeking after short, over-night abstinence periods. Responding under these 
schedules shows often a scalloping pattern with very little initial responding that 
increases towards the end of the interval. A session contains several intervals, typically 
4-5. Responding during the first interval measures drug seeking in the absence of the 
drug, whereas during subsequent intervals the animal has received at least one drug dose 
and is thus under its influence. Response rate as well as the latency to iniate responding 
is influenced by three factors: the conditioned reinforcing properties of the stimulus, the 
anticipation of obtaining the reinforcer available at the end of the interval, and the 
incentive value (strength) of the reinforcer. During the second and subsequent intervals, 
the drug itself contributes to responding by its reinforcing and response-invigorating or 
suppressing effects.  
In contrast to fixed ratio schedules, fixed-interval schedules have been shown to promote 
the development of habitual responding, as there is no linear relationship between 
response rate and reinforcer delivery (Coutureau and Killcross, 2003; Yin et al., 2006). 
This may sometimes confound the interpretation of results, if one wants to dissociate 
motivation from habit as the driving force of drug seeking. 
R e i n s t a t e m e n t  m o d e l s  
In drug seeking studies, reinstatement refers to the resumption of extinguished behavior 
such as lever pressing following exposure to drugs, drug cues, or stress (Shalev et al., 
2002). The reinstatement paradigm can be divided into three phases: self-administration, 
extinction, and reinstatement. During the self-administration phase, the animal is trained 
to self-administer the drug. Studies examining the effects of cues on reinstatement utilize 
this phase to associate stimuli with the delivery of the drug. Therefore the self-
administration phase is often also called the conditioning phase. Different schedules of 
reinforcement, including fixed ratio and second-order schedules, can be used. When the 
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animals have reached stable levels of self-administration and maintained this behaviour 
for some time, extinction training is begun. During extinction the drug is withheld and 
responding has either no programmed consequences or, as often during intravenous self-
administration, results only in the delivery of a neutral solution such as saline. In the 
absence of the reinforcer, response rates may increase during the first session, but during 
subsequent training rapidly decline to very low levels. When extinction responding has 
stabilized, reinstatement testing can begin. Reinstatement can be induced either by 
administering the animal a small dose of the drug, called priming, exposing the animal to 
stimuli (cues) previously associated with drug delivery, or by exposing the animal to a 
stressor like foot shock or food deprivation. Regardless of the reinstatement-inducing 
factor, the drug is not available. However, re-exposure to the priming dose of the drug, 
the drug-associated stimulus, or stress alone is capable of reinstating extinguished 
responding. The number of responses performed by the animal measures the strength of 
reinstatement. As in human addicts, the propensity to relapse is long lasting. Thus, the 
same animals can be tested repeatedly for reinstatement. Reinstatement sessions are 
typically separated by a few days during which the animals either remain in their home 
cages or receive extinction training. In addition to these between-sessions reinstatement 
models, within-session models exist. In these models, animals go through the self-
administration, extinction and reinstatement phases during a single session. 
2.2.2 Alcohol deprivation effect 
Alcohol-seeking behavior can be studied using the reinstatement paradigm described 
above, but in addition, the so-called deprivation model is often used. The alcohol 
deprivation effect (ADE) refers to an increase in alcohol consumption that animals show 
after a period of withdrawal from alcohol access (Sinclair and Senter, 1967). The length 
of the deprivation period is usually between 3 and 14 days, but can range to as long as 
over a year (Lê and Shaham, 2002). The subsequent increase in alcohol consumption is 
temporary and can be seen for some days after which animals return to their pre-
deprivation consumption levels. Factors contributing to increased alcohol consumption 
may include decreased aversive effects (mostly taste) of alcohol (Pinel and Huang, 
1976), an increase in the novelty of the alcohol solution (Sinclair, 1979; Lê and Shaham, 
2002), changes (probably an increase) in the reinforcing properties of alcohol (Heyser et 
al., 1997; Spanagel and Hölter, 2000), or even anticipation of and preparation for future 
deprivation periods (Heyser et al., 1997). The alcohol deprivation effect has sometimes 
been described as a model of relapse in contrast to reinstatement models, as the alcohol 
deprivation model measures actual alcohol consumption after abstinence whereas 
reinstatement paradigms measure drug seeking after extinction without the possibility to 
consume alcohol (Spanagel, 2005). 
2.2.3 Reinstatement of conditioned place preference 
The conditioned place preference method is based on the ability of contextual cues to 
become conditioned to drug effects (see Tzschentke, 1998 for review). The basic 
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procedure consists of a conditioning phase and an expression phase. When the method is 
used to measure reinstatement, an extinction and a reinstatement phase are added.  
The place preference apparatus consists most often of two compartments differing in e.g. 
color, texture, odor, and floor material. During the conditioning phase, animals are 
repeatedly confined to one side of the apparatus after a drug injection and to the other 
side after vehicle injection. During the expression phase, animals are allowed to freely 
explore both compartments in the drug-free state. If the drug effects have been perceived 
as pleasurable during conditioning, animals spend more time in the drug-paired 
compartment., i.e. they show place preference. If the drug has aversive subjective 
effects, animals show an aversion towards the drug compartment (termed conditioned 
place aversion). After the expression test animals can be subjected to an extinction 
phase. Animals are either allowed to freely explore both compartments for several 
sessions or both compartments are repeatedly paired with saline or another neutral 
compound until the preference for the drug-paired compartment has subsided (Mueller 
and Stewart, 2000; Sanchez et al., 2003). Reinstatement of extinguished place preference 
is then induced by injecting the animals with a priming dose of the drug or exposing 
them to a stressor after which the compartments can be explored freely (Mueller and 
Stewart, 2000; Wang et al., 2001; Sanchez et al., 2003). The measure of reinstatement is 
the amount of time spent in the initially drug-paired compartment compared to the 
initially vehicle-paired compartment. 
2.3 Relapse-inducing factors and brain areas involved 
There are three main factors capable of inducing relapse: stress, drug-associated cues, 
and re-exposure to the drug (Self, 1998). Dopamine and glutamate are considered the 
major neurotransmitters mediating drug-seeking behavior, but in addition, several other 
transmitters participate in the regulation of this behavior. Several brain regions are also 
involved (Figure 2.1). The key dopaminergic circuit consists of the dopaminergic 
projections from the ventral tegmental area to the nucleus accumbens, prefrontal cortex, 
and amygdala (McLaughlin and See, 2003; Schmidt et al., 2005). The glutamate system 
regulating drug seeking consists of the prefrontal cortex, hippocampus, and amygdala, 
all of which send glutamatergic projections to the accumbens (Tzschentke and Schmidt,
2003; Kalivas, 2004). In addition, a glutamatergic connection from the amygdala to the 
prefrontal cortex is involved. Alhough the relative strength of these brain areas varies in 
modulating drug seeking induced by different factors – cues, stress, and drug re-
exposure – the circuitries largely overlap. 
20
Figure 2.1. A sagittal rat brain section showing a simplified presentation of the dopaminergic and 
glutamatergic pathways regulating drug-seeking behavior. AMY, amygdala; HIP, hippocampus; N.Acc., 
nucleus accumbens; PFC, prefrontal cortex; VTA, ventral tegmental area. 
2.3.1 Drug re-exposure 
In animal studies, reinstatement is often triggered by administering a small priming dose 
of the drug. Usually, priming is conducted with the training drug but also other drugs can 
induce reinstatement. This is called cross-reinstatement and, from a clinical point of 
view, means that re-exposure to other drugs than the one initially abused may trigger 
relapse. For example, in laboratory animals heroin seeking can be reinstated by heroin, 
but also by morphine, cocaine, and amphetamine (de Wit and Stewart, 1983; De Vries et 
al., 1998), and cocaine seeking can be reinstated by cannabinoid agonists and caffeine 
(Schenk and Partridge, 1999; De Vries et al., 2001).  
Compounds mimicking the subjective or reinforcing effects of the training drug are often 
found to reinstate drug seeking. This is however not always the case (Spealman et al., 
1999). The priming effects of cocaine, which is an indirect dopamine, norepinephrine 
and serotonin agonist, can be mimicked by dopamine agonists of the D2 type, whereas 
administration of D1 type dopamine agonists does not result in reinstatement (Khroyan 
et al., 2000). The subjective effects of both D1 and D2 agonists are, however, similar to 
cocaine, at least as measured by the drug discrimination paradigm, where animals are 
trained to make a certain response if the test drug (in this case dopamine agonist) 
resembles the training drug (cocaine) (Spealman et al., 1991). This indicates that in 
addition to the subjective effects of the priming drug, other properties can regulate drug-
seeking behavior. 
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Reinstatement induced by drug priming is mediated mainly by the nucleus accumbens 
and the prefrontal cortex. A priming injection of cocaine elevates extracellular dopamine 
and glutamate levels in the nucleus accumbens and dopamine levels in the prefrontal 
cortex (McFarland et al., 2003). The ventral tegmental area, which projects to the 
nucleus accumbens and prefrontal cortex, also contributes to drug-seeking behavior as 
inactivation of this brain region attenuates cocaine-induced reinstatement (McFarland 
and Kalivas, 2001). Reinstatement induced by drug priming has been hypothesized to 
activate the VTA-prefrontal cortex dopamine projection, leading to elevated prefrontal 
dopamine levels, after which the glutamatergic projection from the prefrontal cortex to 
the nucleus accumbens is critical (McFarland and Kalivas, 2001; McFarland et al., 
2003).  Priming dose –induced reinstatement can be blocked by inactivation of any of 
the brain regions in this circuitry (McFarland and Kalivas, 2001) and also by attenuation 
of dopamine transmission in the prefrontal cortex or glutamate transmission in the 
nucleus accumbens (Cornish and Kalivas, 2000; McFarland and Kalivas, 2001; Park et 
al., 2002; Sanchez et al., 2003; Sun and Rebec, 2004; Peters and Kalivas, 2006). 
However, dopamine transmission in the accumbens is probably also involved, as 
accumbal dopamine antagonism attenuates cocaine-induced reinstatement (Anderson et 
al., 2003; but see Cornish and Kalivas, 2000; McFarland and Kalivas, 2001). 
2.3.2 Stress
The most common stressor used in relapse studies is footshock, a small electrical current 
delivered through the grid floor of the operant box. Footshock stress has been found to 
reinstate alcohol, cocaine, heroin, and nicotine seeking (Erb et al., 1996; Shaham et al., 
1996; Lê et al., 1998; Buczek et al., 1999). Other stressors that have been used include 
acute 1-day food deprivation (Shalev et al., 2000), forced swimming (Kreibich and Blendy, 
2004), and administration of the stress hormone corticotropin-releasing factor (CRF) 
(Shaham et al., 1997; Shaham et al., 2003), the levels of which have been shown to be 
elevated following footshock stress (Wang et al., 2005). Selective CRF1 or nonselective 
CRF receptor antagonists attenuate footshock-induced reinstatement of heroin, cocaine, 
and alcohol seeking (Shaham et al., 1997; Erb et al., 1998; Shaham et al., 1998; Lê et al., 
2000). The neurotransmitter noradrenaline is also implicated in stress-induced relapse. ?2-
adrenergic antagonists, which increase noradrenergic cell firing, induce reinstatement (Lee 
et al., 2004; Shepard et al., 2004), whereas ?2-adrenergic agonists attenuate footshock-
induced reinstatement of heroin, cocaine, as well as speedball (a combination of heroin and 
cocaine) seeking (Erb et al., 2000; Shaham et al., 2000; Highfield et al., 2001). The brain 
stuctures critically involved in stress-induced reinstatement include the bed nucleus of the 
stria terminalis and the central nucleus of the amygdala (Shaham et al., 2000; Erb et al., 
2001), both of which receive noradrenergic connections from the noradrenergic lateral 
tegmental cell groups and also contain CRF receptors (Shaham et al., 2000; Shaham et al., 
2003). The central nucleus of the amygdala has been hypothesized to activate the ventral 
tegmental area and its dopaminergic projections, thus increasing dopamine levels in the 
prefrontal cortex (McFarland et al., 2004). The dopamine rise would induce reinstatement 
by activating the glutamatergic projection from the prefrontal cortex to the nucleus 
accumbens (McFarland et al., 2004). 
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Food-deprivation –induced reinstatement is thought to involve the adrenal hormone 
corticosterone and leptin, a hormone secreted by adipose tissue and involved in energy 
balance and body weight regulation (Shalev et al., 2001; Shalev et al., 2003). 
Intracerebroventricular administration of leptin decreases food intake and increases 
energy use (Ahima and Flier, 2000), but is also able to attenuate heroin seeking induced 
by a 1-day food deprivation (Shalev et al., 2001). Leptin has however no effect on heroin 
seeking induced by footshock or a priming injection (Shalev et al., 2001).  
Orexin (hypocretin), a neuropeptide that controls sleep, arousal, and feeding, also mediates 
reinstatement of drug seeking (Carr and Kalivas, 2006). Activation of orexin neurons in the 
lateral hypothalamus or orexin receptors in the terminal field of this projection, the ventral 
tegmental area, reinstates morphine seeking (Harris et al., 2005). Intrecerebroventicular 
administration of orexin also reinstates cocaine seeking, an effect that can be prevented by 
blockade of noradrenergic or CRF systems, suggesting that the effects of orexin are at least 
partly mediated via activation of stress pathways (Boutrel et al., 2005). 
2.3.3 Cues 
Reinstatement induced by cues, i.e. drug-associated stimuli, involves the process of 
classical conditioning. As a result of repeated association with drug exposure, the stimuli 
acquire the ability to trigger drug-seeking behavior when presented in the absence of the 
drug (Self, 1998). Cues can be either discrete, discriminative, or contextual. Discrete 
cues are stimuli (e.g. tones or lights) presented simultaneously with drug delivery, 
whereas discriminative cues signal drug availability. For example, in the presence of a 
discriminative light stimulus responding on a lever in the test chamber is reinforced with 
drug delivery, whereas in the absence of the light responding has no consequences. 
Contextual cues are part of the self-administration environment. For example, two 
chambers differing in terms of size, color, material, and odor can be used for 
conditioning, extinction, and reinstatement sessions. Self-administration training and 
conditioning is conducted in one chamber, after which extinction training is carried out 
in the other chamber. Extinguished responding can then be reinstated, or renewed, by 
exposing the animals to the first chamber during reinstatement sessions. In addition to 
physical differences, the contexts may deviate also in interoceptive or circadian elements 
such as the time of testing.  
Reinstatement induced by different kinds of cues is in most cases similarly modulated by 
pharmacological manipulations (Bossert et al., 2005). Dopamine antagonism attenuates 
reinstatement induced by discrete, discriminative, and contextual cues in a similar 
manner (Weiss et al., 2001; Alleweireldt et al., 2002; Crombag et al., 2002). Dopamine 
antagonists are effective also when injected directly into the amygdala, more precisely 
the basolateral region, indicating that the amygdala is involved in cue-induced drug 
seeking (See et al., 2001; Alleweireldt et al., 2006). This is further supported by findings 
that inactivation and lesions of the amygdala attenuate reinstatement induced by discrete, 
discriminative, and contextual cues (Meil and See, 1997; Fuchs and See, 2002; Yun and 
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Fields, 2003; Fuchs et al., 2005). In addition, the nucleus accumbens and glutamate 
transmission therein are critically involved. Accumbal glutamate receptor blockade 
decreases cue-controlled drug seeking under a second-order schedule of self-
administration and dampening glutamate release attenuates cue-induced reinstatement 
(Di Ciano and Everitt, 2001; Baptista et al., 2004). Inactivation studies have shown that 
the hippocampus, ventral tegmental area, and prefrontal cortex also modulate cue-
induced drug seeking (McLaughlin and See, 2003; Sun and Rebec, 2003; Di Ciano and 
Everitt, 2004; Fuchs et al., 2004). The hippocampus may however be more strongly 
involved in drug seeking induced by drug-associated contexts than discrete cues, as 
hippocampal inactivation was found to inhibit reinstatement induced by contextual but 
not discrete cues (Fuchs et al., 2005).  
Human addicts are exposed to a vast array of stimuli during the acquisition and 
consumption of drugs. Although reinstatement can be induced by a single stimulus, 
compound stimuli have been shown to be more effective in animal studies (See et al., 
1999). The constituents of the compound stimulus used during testing can also be 
conditioned separately as single stimuli. In a study where rats had been trained to 
associate a light and a tone separately as discriminative stimuli signalling food 
availability (i.e. food was available during presentation of either the light or the tone but 
not in their absence) responding was significantly higher in the presence of a light+tone 
compound stimulus than either the light or tone alone (Kearns and Weiss, 2005). 
Depending on the compound stimulus and the sensory modalities of its components, one 
component may dominate and thus induce stronger reinstatement than the others if 
presented alone. Reinstatement may also be completely absent, if the constituents are 
presented alone. In a study by See et al. (1999) this was examined by training rats to 
associate different kinds of discrete stimuli with cocaine delivery. Thereafter, responding 
was extinguished in the absence of the stimuli and the effects of different combinations 
of the stimulus components on reinstatement responding were examined. Rats that had 
been trained with a light and tone compound stimulus showed reinstatement of 
responding following presentation of the compound stimulus. However, neither of the 
stimulus constituents (light or tone) alone reinstated responding in these animals. When 
rats were trained with a single stimulus (either light or tone), the light stimulus was 
found to induce modest reinstatement, whereas a similarly conditioned and presented 
tone was ineffective. 
Another important issue in animal reinstatement studies is the manner in which the 
stimulus is presented. Discrete cues can be presented either response-contingently, i.e. as 
a consequence of behavior or noncontingently, without any effort from the animal. 
Reinstatement induced by discrete cues has been found to be stronger following 
contingent than noncontingent stimulus presentation (Meil and See, 1996; Grimm et al., 
2000; Di Ciano and Everitt, 2003). This may be related to stimulus compounding, as a 
stimulus that has been presented simultaneously with drug delivery during conditioning 
has usually also been presented in close temporal relationship with the response (e.g. 
lever press). Thus, the response (lever press) may have been incorporated in the 
compound stimulus (Grimm et al., 2000). A similar phenomenon has been observed in 
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addicts: those that were allowed to touch and manually examine cues (drug-related 
paraphernalia) showed greater craving and changes in physiological measures such as 
pulse, skin conductance, and temperature (Johnson et al., 1998). 
2.4 Neuropharmacology of drug seeking 
2.4.1 Dopamine 
T h e  m e s o c o r t i c o l i m b i c  d o p a m i n e  s y s t e m  
Most addictive drugs increase dopamine levels in the terminal fields of the 
mesocorticolimbic dopamine system (Di Chiara and Imperato, 1988). The cell bodies of 
dopamine neurons reside in the ventral tegmental area (VTA), from where projections 
extend to the nucleus accumbens, prefrontal cortex, and amygdala (Koob, 1992). Drug 
taking in laboratory animals can be modified by dopamine receptor agonist and antagonist 
injections administered either systemically or into the terminal fields of the dopamine 
system. Dopamine antagonists tend to attenuate, whereas agonists enhance, the reinforcing 
properties of e.g. cocaine (Hubner and Moreton, 1991; Caine and Koob, 1994; Caine et al., 
1995; Caine and Koob, 1995). Drug-seeking behavior can be attenuated by inactivation of 
the VTA or any of the terminal regions of the mesolimbic dopamine system (McLaughlin 
and See, 2003; Di Ciano and Everitt, 2004; McFarland et al., 2004). 
D o p a m i n e  r e c e p t o r s  
Dopamine receptors are divided into two major groups, D1-like and D2-like receptors, 
based on their effects on the activity of adenylate cyclase, an enzyme responsible for the 
transformation of adenosine triphosphate (ATP) into cyclic adenosine monophosphate 
(cAMP), an intracellular second messenger. The D1-like receptors, which include D1 and 
D5 receptors, stimulate adenylate cyclase, whereas the D2-like receptors D2, D3, and D4
inhibit it (Nestler et al., 2001).  
D o p a m i n e  a n d  d r u g  s e e k i n g  
Drug priming increases accumbal dopamine levels (Di Ciano et al., 2001; McFarland et 
al., 2003) and drug-seeking behavior can be induced by injecting dopamine or dopamine 
agonists into the nucleus accumbens (Cornish and Kalivas, 2000; Park et al., 2002; 
Bachtell et al., 2005). Conversely, inactivation of the nucleus accumbens or intra-
accumbal infusions of dopamine receptor antagonists attenuate reinstatement induced by 
drug priming or footshock stress (Di Ciano and Everitt, 2004; McFarland et al., 2004; Xi 
et al., 2004; Bachtell et al., 2005; Anderson et al., 2006; but see McFarland and Kalivas, 
2001). Similar to drug priming, the presentation of drug-associated cues leads to 
elevations, although less pronounced, in accumbal dopamine levels (Katner and Weiss, 
1999; Weiss et al., 2000). Although there are no direct studies examining the effects of 
accumbal dopamine receptor blockade on cue-induced drug seeking, the ability of a 
discriminative stimulus to guide behavior has been shown to be impaired following 
dopamine antagonist injections into the nucleus accumbens (Yun et al., 2004). 
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In addition to the accumbens, drugs of abuse elevate dopamine levels also in the 
prefrontal cortex (Sorg and Kalivas, 1993) and reinstatement can be induced by 
dopamine agonist administration into this brain region (McFarland and Kalivas, 2001; 
Park et al., 2002). In fact, elevated prefrontal dopamine levels have been suggested to be 
one of the initiators of drug-seeking behavior (McFarland and Kalivas, 2001). Therefore, 
it is not surprising that D1 and D2 dopamine receptor antagonism in the prefrontal cortex 
attenuates reinstatement induced by a priming dose of cocaine (McFarland and Kalivas, 
2001; Park et al., 2002; Sanchez et al., 2003; Sun and Rebec, 2004) or footshock stress 
(Sanchez et al., 2003; McFarland et al., 2004).  
Dopamine transmission in the amygdala is an important mediator of cue-induced 
reinstatement. Cocaine-associated discriminative stimuli, which reinstate drug seeking, 
increase dopamine levels also in the amygdala (Weiss et al., 2000) and infusions of d-
amphetamine, an indirect dopamine agonist, into the basolateral amygdala enhance 
reinstatement induced by cocaine-associated cues (Ledford et al., 2003). In line with this, 
reinstatement induced by cocaine-associated stimuli can be attenuated by D1 or 
combined D1/D2 antagonism in the amygdala, whereas glutamate receptor antagonism is 
ineffective (See et al., 2001).  
D1- and D2-type dopamine antagonists attenuate drug seeking also when injected 
systemically. For example, heroin, cocaine, and nicotine seeking induced by drug 
priming (Shaham and Stewart, 1996; Khroyan et al., 2000; Andreoli et al., 2003) as well 
as cue-induced cocaine and alcohol seeking (Alleweireldt et al., 2002; Liu and Weiss, 
2002) and stress-induced cocaine seeking (Xi et al., 2004) can be attenuated by 
dopamine receptor antagonists. Surprisingly, a similar result has been reported with D1 
agonists. Systemically administered D1-like agonists do not reinstate drug seeking like 
dopamine, nonselective dopamine agonists, and D2-like agonists do, but actually 
attenuate priming and cue-induced reinstatement (Self et al., 1996; Khroyan et al., 2000; 
Alleweireldt et al., 2002). The reason for this is largely unclear. In a study by 
Alleweireldt et al. (2003) a decrease in cue- or priming-induced cocaine seeking could 
be accomplished by either D1 antagonism or D1 agonism. When co-administered, the 
antagonist and agonist were found to be ineffective in modulating reinstatement induced 
by a cocaine priming dose. With cue reinstatement, no such interaction was found and 
reinstatement was attenuated similarly as following D1 agonism alone. A similar effect 
was discovered by Khroyan et al. (2000) on drug seeking induced by cocaine priming 
together with cocaine-associated cues: the reinstatement-attenuating effects of a D1 
agonist or a D1 antagonist administered alone were partially reversed when the 
compounds were co-administered. This suggests that cocaine-induced reinstatement is 
dependent on an optimal level of dopamine receptor stimulation. Therefore, both 
overstimulation with agonists and understimulation with antagonists can abolish 
reinstatement. As for the different results between cue- and priming-induced 
reinstatement, several explanations are possible including higher extracellular dopamine 
levels following a priming dose of cocaine as compared to cue presentation and different 
populations or subtypes of D1 dopamine receptors involved. Inactivation studies have 
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shown that although the amygdala is involved in both cue and priming dose induced 
reinstatement (Fuchs and See, 2002; Yun and Fields, 2003), it may be more important in 
modulating cue-induced drug seeking (Grimm and See, 2000; McFarland and Kalivas, 
2001). It has been hypothesized that in the amygdala most D1 receptors are probably not 
coupled to adenylate cyclase (Kilts et al., 1988; Alleweireldt et al., 2003), but possibly to 
phospholipase C (Alleweireldt et al., 2003). If so, this may be important as the effects of 
dopaminergic compounds often differ between adenylate cyclase and phospholipase C –
coupled receptors, even to such an extent that no correlation has been found between the 
potencies or efficacies in stimulating these two receptors subtypes (Undie et al., 1994). 
For example, one of the D1 agonists used in the above studies, SKF81297, is classified 
as a full agonist at the adenylate cyclase -linked receptor but only as a partial agonist at 
the phospholipase C -linked receptor (Undie et al., 1994). Thus, partial agonism at 
amygdalar D1 receptors may not have been enough to counteract the effects of D1 
antagonism on drug seeking. 
2.4.2 Glutamate 
T h e  c o r t i c o l i m b i c  g l u t a m a t e  s y s t e m  
Glutamate is the principal excitatory neurotransmitter in the mammalian central nervous 
system. With regard to drug addiction and drug-seeking behavior, glutamate transmission 
in the nucleus accumbens and its afferent projections plays a central role. The nucleus 
accumbens as well as the the ventral tegmental area (VTA) receive glutamatergic 
projections from the amygdala, prefrontal cortex, and hippocampus (Tzschentke and 
Schmidt, 2003). The VTA is the cell body region of the mesolimbic dopamine system, and 
therefore the nucleus accumbens and the VTA are sites of glutamate-dopamine 
interactions. In the VTA, glutamate increases the activity of dopaminergic neurons, which 
results in increased dopamine release in the accumbens (Kretschmer, 1999). At the level of 
the nucleus accumbens, research on glutamatergic modulation of dopamine 
neurotransmission has produced complex and controversial data, but it seems that 
glutamate receptors can differentially modulate impulse-dependent and impulse-
independent dopamine release (see David et al., 2005 for a review). 
G l u t a m a t e  r e c e p t o r s  
Glutamate receptors are divided into ionotropic receptors, which are intrinsic to an ion 
channel, and metabotropic receptors, which are G-protein coupled (Figure 2.2.). 
Ionotropic receptors are further subdivided into NMDA, AMPA, and kainate receptors, 
whereas metabotropic glutamate receptors (mGluR) are comprised of 8 subtypes 
(mGluR1-8) belonging to three groups (I-III) (Witkin et al., 2002; David et al., 2005).  
27
Figure 2.2. The major glutamate receptor subtypes in a hypothetical synapse. Shown are the G-protein 
coupled metabotropic glutamate receptors (mGluR) with their second messengers phospolipase C and 
adenylate cyclase and the ionotropic receptor channels with the ions to which they are mainly permeable. In 
the lower part, the receptor subtypes comprising each group (I-III) of metabotropic receptors are listed. For 
ionotropic receptors, the subunits from which the different receptors are composed are shown. Adapted from 
Bleakman and Lodge, Neuropharmacology (1998) 37:1187-1204. 
NMDA receptors are composed of NR1 and NR2 subunits, of which NR1 has eight different 
splice variants and NR2 four different subtypes (NR2A-D). In the brain NMDA receptors are 
believed to exist as NR1-NR2 heteromeric complexes (Nestler et al., 2001; Waxman and 
Lynch, 2005). The pharmacological properties of NMDA receptors are influenced by their 
subunit composition in terms of agonist affinity, antagonist sensitivity, desensitization, and 
sensitivity to Mg2+ blockade (see Yamakura and Shimoji, 1999 for review).  
Presynaptic terminal
Glutamate
mGluR II/III Kainate
mGluR II/IIImGluR I AMPA KainateNMDA
Ca2+
Na+
Na+
Ca2+
Na+
Ca2+
G protein G protein
Phospholipase C
Adenylate cyclase
Group I 
mGluR1 
mGluR5
Group III
mGluR4 
mGluR6
mGluR7
mGluR8
Group II
mGluR2 
mGluR3
Metabotropic receptors Ionotropic receptors
Subunits
NR1
NR2A
NR2B
NR2C
NR2D
GluR1
GluR2
GluR3
GluR4
GluR5
GluR6
GluR7
KA1
KA2
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NMDA receptor function can be modulated through several binding sites: glutamate, 
glycineB, polyamine, and phencyclidine sites. Competitive agonists and antagonists bind 
at the glutamate site whereas noncompetitive ligands bind at one of the other binding 
sites. Glycine is required as a co-agonist with glutamate for receptor activation. Under 
physiological conditions, however, the glycine concentration is believed to always be 
sufficient. The polyamine site potentiates receptor function in a pH-dependent fashion. 
The phencyclidine site is located within the receptor ion channel and its blockers are 
called uncompetitive antagonists. In addition to both glutamate and glycine, proper 
functioning of NMDA receptors requires a depolarization to release a Mg2+ block from 
the channel. One consequence of the Mg2+ block is that channel blockers (uncompetitive 
antagonists) are able to access their binding site only following receptor activation 
(Nestler et al., 2001). Compared to AMPA receptors, the affinity of NMDA receptors for 
glutamate is about 500 times higher, but because of the voltage-dependent Mg2+ block 
NMDA receptors are thought to contribute less to basal synaptic glutamate transmission 
(Simeone et al., 2004). However, after the NMDA receptor -containing neurons have 
been depolarized by activation of other receptors, the contribution of NMDA receptors 
to glutamatergic transmission can be substantial. 
AMPA receptor are comprised of four subunits, GluR1-4, which most likely can 
assemble in all combinations as homomers or heteromers (Nestler et al., 2001). As with 
NMDA receptors, the subunit composition influences e.g. receptor desensitization 
(Dingledine et al., 1999). Compared to NMDA receptors, AMPA receptors have fewer 
binding sites. Competitive ligands bind at the glutamate recognition site whereas 
noncompetitive modulators bind at a distinct allosteric regulatory site. In addition, those 
AMPA receptors that lack the GluR2 subunit and are therefore permeable to Ca2+ can be 
antagonized by cationic channel blockers such as certain spider and wasp toxins. The 
function of kainate receptors, comprised of GluR5-7 and KA1-2 subunits, was until 
recently poorly understood because of the lack of selective agonists and antagonists 
(Witkin et al., 2002). Kainate receptors may however be future targets for the treatment 
for drug addiction as they have been found in the amygdala, one of the brain regions 
modulating drug-seeking behavior (Braga et al., 2004). 
Metabotropic glutamate receptors are divided into three groups. Group I is comprised of 
mGlu1 and mGlu5 receptors, group II of mGlu2 and 3 receptors, and group III of mGlu4 
and mGlu6-8 receptors. Group I mGlu1/5 receptors are predominantly postsynaptic, 
whereas group II and III agonists can negatively modulate glutamate transmission via a 
presynaptic mechanism (Schoepp, 2001; Thomas et al., 2001; Pothecary et al., 2002). 
Therefore, group I antagonists and group II/III agonists can have similar effects: group I 
antagonists by decreasing glutamate input to postsynaptic cells and group II/III agonists 
by decreasing the amount of glutamate released from presynaptic terminals. 
E f f e c t s  o f  r e p e a t e d  d r u g  t r e a t m e n t  o n  g l u t a m a t e r g i c  
n e u r o t r a n s m i s s i o n  
Repeated drug treatment has been shown to change glutamatergic transmission in a way 
that increases the ability of drug-associated cues, drug priming, and stressors to trigger 
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relapse. The majority of studies have measured extracellular glutamate levels using the 
in vivo microdialysis technique. However, glutamate differs from e.g. dopamine in that 
its synaptic pool can rarely be sampled under physiological conditions as glutamate is 
rapidly cleared from the synapse after its release (Drew et al., 2004). Because of this the 
physiological origin of glutamate detected by microdialysis is uncertain and basal levels 
may mostly be of extrasynaptic or non-neuronal origin (Oldenziel et al., 2006). The role 
of glutamate released independently from neuronal activity should however not be 
belittled, as it may still contribute to the control of neuronal excitability under normal 
and pathological conditions (Nyitrai et al., 2006). 
When animals have been repeatedly treated with a drug, so far all studies have used 
cocaine, decreased basal levels of extracellular glutamate are observed in the nucleus 
accumbens (Bell et al., 2000; Hotsenpiller et al., 2001; Baker et al., 2003; McFarland et 
al., 2003). This decrease in glutamate levels probably requires the pairing of the drug 
with environmental stimuli or cues, as so called “unpaired” rats, i.e. animals treated with 
cocaine in their home cage, mostly fail to show decreased glutamate levels when 
compared to rats for which the treatment has been paired with a distinct environment 
(thus called “paired” rats) (Bell et al., 2000; Hotsenpiller et al., 2001). 
Upon re-exposure to either cocaine or cocaine-paired stimuli, a second change in 
glutamate transmission is observed. Compared to controls, repeatedly cocaine-treated 
animals show an enhanced glutamate release in the nucleus accumbens (Bell et al., 2000; 
Hotsenpiller et al., 2001; Baker et al., 2003; McFarland et al., 2003). As shown by 
McFarland et al. (2003), this increase is dependent on neuronal activation (i.e., sensitive 
to Na+-channel blockade by tetrodotoxin). As with decreased basal glutamate levels, the 
enhanced glutamate release is observed only in animals in which cocaine has previously 
been paired with environmental stimuli, or in animals that have been self-administering 
cocaine. McFarland et al. (2003) showed also that a priming injection of cocaine to 
reinstate drug seeking increased glutamate release in rats that had been self-
administering cocaine, but not in their yoked counterparts. The yoked and self-
administering rats had received an equal amount of cocaine during the self-
administration phase and similar treatment during cocaine withdrawal. In fact, the yoked 
rats even showed decreased basal glutamate levels, probably as a result of pairing 
cocaine with the self-administration chamber, but the enhanced glutamate release 
following cocaine priming was absent. This demonstrates that although passive exposure 
to cocaine can result in changes in glutamatergic neurotransmission, additional changes 
take place when experimenter-administered cocaine is paired with environmental stimuli 
or the drug is contingent upon the behavior of the animal. At the same time, the above 
experiments show that both cocaine priming and exposure to cocaine-associated stimuli 
elevate glutamate levels in the nucleus accumbens.  
Repeated drug treatment has also been shown to induce changes in the glutamatergic 
responses to stress. Footshock stress has been found to increase glutamate levels in the 
ventral tegmental area of cocaine-treated, but not naïve, rats. Further examination 
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revealed that glutamate release was under the control of CRF and induced drug seeking 
indirectly, through activation of the mesolimbic dopamine system (Wang et al., 2005). 
The increased glutamate release observed following cocaine priming and also 
reinstatement of cocaine seeking can be blocked by administration of the amino acid 
cystine (Baker et al., 2003). Cystine is the substrate for a carrier that exchanges 
extracellular cystine for intracellular glutamate (see Baker et al., 2002). The decreased 
basal glutamate levels following repeated cocaine treatment may result from decreases in 
this exchange process. In cocaine-naïve animals, blockade of the cystine/glutamate 
exchange in the nucleus accumbens was shown to result in decreased extracellular 
glutamate levels similar to cocaine withdrawal. When repeatedly cocaine-treated rats, 
which showed the characteristic decreased glutamate levels, were treated with 
exogenous cystine, normal glutamate levels were restored (Baker et al., 2002). The 
administration of cystine also abolished the ability of a cocaine priming injection to 
reinstate cocaine seeking. Microdialysis data showed that in cystine-treated rats the 
cocaine priming injection was no longer able to elevate glutamate levels above normal 
baseline levels (Baker et al., 2003) suggesting that the elevated accumbal glutamate 
levels mediate reinstament. It has been suggested that glutamate derived from the 
cystine/glutamate exchanger provides endogenous tone at extrasynaptic group II 
metabotropic glutamate receptors, thus decreasing the (cocaine-induced) release of 
glutamate and possibly also other transmitters such as dopamine, depending on whether 
the receptors function as auto- or heteroreceptors (Baker et al., 2002). 
G l u t a m a t e  a n d  d r u g  s e e k i n g  
Evidence for the involvement of accumbal glutamate transmission in drug-seeking 
behavior comes from studies in which drug seeking was induced by injections of either 
AMPA or NMDA type glutamate agonists into the nucleus accumbens (Cornish et al., 
1999; Cornish and Kalivas, 2000; Suto et al., 2004). Further, reinstatement induced by 
either systemically administered cocaine, intra-accumbal dopamine, or an intra-accumbal 
AMPA receptor agonist can be attenuated by blockade of accumbal AMPA receptors 
(Cornish and Kalivas, 2000). Interestingly, in this study an AMPA antagonist blocked 
reinstatement by all compounds, whereas a dopamine antagonist blocked only 
dopamine-induced reinstatement. This finding suggests that accumbal glutamate may be 
more important than dopamine in regulating drug seeking. 
Accumbal glutamate transmission modulates also drug seeking induced by drug-
associated stimuli. Glutamate receptor blockade in the nucleus accumbens or more 
dorsal parts of the striatum has been fount to attenuate cocaine seeking under a second-
order schedule of self-administration (Di Ciano and Everitt, 2001; Vanderschuren et al., 
2005). Interestingly, these data suggest that antagonism at AMPA, but not NMDA 
glutamate receptors decreases drug seeking. A similar finding has been reported by 
Cornish and Kalivas (2000) with regard to priming-induced reinstatement. Also an 
anatomical dissociation has been found. It seems that within the nucleus accumbens, the 
core area may be more important than the shell in modulating both priming dose and 
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cue-induced drug seeking (Di Ciano and Everitt, 2001; McFarland and Kalivas, 2001; 
Fuchs et al., 2004; Ito et al., 2004; Yao et al., 2005; but see Bossert et al., 2005). 
The nucleus accumbens receives glutamatergic projections from the amygdala, 
hippocampus, and prefrontal cortex. Inactivation of the prefrontal cortex with GABA 
agonists prevents cocaine-induced elevations in accumbal glutamate levels (Pierce et al., 
1998; McFarland et al., 2003) as well as reinstatement induced by either cocaine priming 
(McFarland and Kalivas, 2001; Capriles et al., 2003) or drug-associated cues 
(McLaughlin and See, 2003). In addition, lesions of the prefrontal cortex disrupt the 
ability of drug-associated stimuli to guide behavior under a second-order schedule of 
reinforcement (Weissenborn et al., 1997). Park et al. (2002) provided futher support for 
the role of the glutamatergic projection from the prefrontal cortex to the accumbens by 
showing that reinstatement induced by cocaine injected into the prefrontal cortex can be 
blocked by accumbal AMPA antagonism. 
The amygdala sends glutamatergic projections both to the nucleus accumbens and the 
prefrontal cortex. Within the basolateral amygdala glutamate receptor blockade is 
ineffective in modulating cue-induced reinstatement (See et al., 2001). This does not 
mean that the glutamatergic projections originating in the amygdala would not 
participate in the regulation of drug-seeking behaviour. Several inactivation and lesion 
studies have shown the involvement of the amygdala in both priming dose and cue-
induced relapse (Grimm and See, 2000; Fuchs and See, 2002; Yun and Fields, 2003; but 
see Di Ciano and Everitt, 2004) and, underlining the importance of glutamate, a study by 
Di Ciano and Everitt (2004) showed that serial interactions between the amygdala and 
the nucleus accumbens are crucial for drug seeking guided by cues. Unilateral injections 
of a dopamine antagonist into the amygdala and an AMPA/kainate glutamate antagonist 
into the nucleus accumbens core, neither of which had any effects when injected alone, 
attenuated drug-seeking behavior under a second-order schedule of self-administration 
(Di Ciano and Everitt, 2004). 
Although the nucleus accumbens and the VTA receive glutamatergic projections from 
the hippocampus, the role of these projections in drug-seeking behavior has not been 
systematically explored. Studies so far have however found that inactivation of the 
hippocampus attenuates priming dose and cue-induced drug seeking (Sun and Rebec, 
2003; Fuchs et al., 2005) and, more importantly, that stimulation of the hippocampus 
induces cocaine seeking through activation of ionotropic glutamate receptors in the 
ventral tegmental area (Vorel et al., 2001). Within the VTA, cocaine-primed 
reinstatement can be attenuated by ionotropic glutamate receptor blockade (Sun et al., 
2005). Also metabotropic glutamate receptors in the VTA modulate drug seeking as 
infusions of an mGluR2/3 agonist, which decreases presynaptical glutamate release, 
were reported to attenuate context-induced heroin seeking (Bossert et al., 2004). 
The majority of studies examining the effects of systemically administered glutamate 
receptor agonists and antagonists on reinstatement of drug-seeking behavior have targeted 
metabotropic receptors. Most studies have employed either LY379268, an mGluR2/3 
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agonist, or MPEP, an mGluR5 antagonist. Presumably, both compounds dampen 
glutamatergic neurotransmission; LY379268 by a presynaptic, release-decreasing effect, 
and MPEP by a postsynaptic effect. MPEP has been found to attenuate priming-induced 
cocaine and nicotine seeking (Tessari et al., 2004; Lee et al., 2005) and cue-induced 
nicotine seeking (Bespalov et al., 2005). The mGluR2/3 agonist LY379268 has so far been 
reported to attenuate priming dose induced cocaine seeking (Adewale et al., 2006; Peters 
and Kalivas, 2006) and cue-induced heroin and cocaine seeking (Baptista et al., 2004; 
Bossert et al., 2004; Bossert et al., 2005), showing that drug seeking induced by both drug 
re-exposure and drug-associated stimuli is modulated by metabotropic glutamate receptors. 
This could be an exciting finding, as medications targeting metabotropic instead of 
ionotropic receptors might have fewer side effects (Spooren et al., 2000; Breysse et al., 
2002). These hopes may, however, be somewhat premature as there are some recent 
studies showing that both LY379268 and MPEP may possess undesirable effects (Harrison 
et al., 2002; Kenny et al., 2005; Peters and Kalivas, 2006). 
There are surprisingly few studies on the effects of systemically administered ionotropic 
glutamate receptor agonists and antagonists on drug-seeking behavior. A study by De 
Vries et al. (1998) showed reinstatement of cocaine-seeking behavior following systemic 
administration of the uncompetitive NMDA antagonist MK-801. This is interesting, as 
intracranially injected AMPA antagonists have been reported to decrease drug seeking 
(see above). However, systemic MK-801 has been shown to induce a delayed increase in 
accumbal glutamate levels (Ito et al., 2006) and another uncompetitive NMDA 
antagonist, phencyclidine, similarly increases both extracellular glutamate and dopamine 
levels in the nucleus accumbens and prefrontal cortex (Adams and Moghaddam, 1998). 
If systemic administration of uncompetitive NMDA antagonists increases accumbal and 
prefrontocortical transmitter levels similar to drug-associated cues and/or drug priming, 
this might explain the potentiating effect of MK-801 on drug seeking. However, 
memantine, which is also an uncompetitive antagonist, has been reported to attenuate 
morphine-induced reinstatement of conditioned place preference (Popik et al., 2006) 
whereas another uncompetitive antagonist, neramexane, did not reach significance in 
reducing cue-induced alcohol-seeking in a study by Bachteler et al. (2005). The 
functional NMDA antagonist acamprosate, in its turn, attenuates cue-induced alcohol 
reinstatement (Bachteler et al., 2005). This suggests that systemically administered 
NMDA antagonists, at least uncompetitive channel blockers, may differentially 
modulate reinstatement behavior. 
In contrast, systemically administered competitive, uncompetitive, and NMDA/glycine 
antagonists have all been found to attenuate alcohol relapse as measured by the alcohol 
deprivation model (Hölter et al., 1996; Heyser et al., 1998; Hölter et al., 2000; 
Vengeliene et al., 2005). Administration of ethanol also decreases the alcohol 
deprivation effect, suggesting that alcohol drinking after deprivation is driven by the 
pharmacological effects of alcohol (Vengeliene et al., 2005). It has also been found that 
uncompetitive, competitive, and glycine site antagonists of the NMDA receptor are all 
capable of substituting for ethanol in drug-discrimination studies, i.e. they induce 
ethanol-like subjective effects (Kotlinska and Liljequist, 1997; Bienkowski et al., 1998; 
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Hölter et al., 2000). Ethanol itself inhibits NMDA receptor function via a 
noncompetitive mechanism (Krystal et al., 2003). Thus, NMDA antagonists probably 
substitute for ethanol during alcohol re-access and decrease deprivation-induced relapse-
like drinking through this mechanism. 
The role of glutamate in relapse induced by stressors has been less extensively studied. 
However, footshock stress has been found to increase dopamine and glutamate release in the 
prefrontal cortex and ventral tegmental area as well as glutamate, but not dopamine, release 
in the nucleus accumbens core (McFarland et al., 2004). Inactivation of the prefrontal cortex, 
which sends glutamatergic projections to the accumbens, blocked the stress-induced rise in 
accumbal glutamate levels and cocaine seeking (McFarland et al., 2004). In the VTA, 
footshock stress has been found to elevate levels of the stress hormone corticotrophin-
releasing factor (CRF), glutamate, and dopamine in cocaine-experienced animals (Wang et 
al., 2005). Stress-induced increases in dopamine and glutamate levels as well as stress-
induced reinstatement were blocked by intra-VTA infusions of a CRF antagonist. Similarly, 
blockade of ionotropic glutamate receptors blocked the increases in dopamine levels and 
reinstatement (Wang et al., 2005). Thus, stress probably acts to increase VTA CRF levels, 
which in turn increase local glutamate release. Glutamate activates dopaminergic projections 
to the accumbens and prefrontal cortex, brain regions where dopamine has been shown to 
induce drug-seeking behavior (McFarland et al., 2004). 
L e n g t h  o f  w i t h d r a w a l  p e r i o d  a n d  d r u g  s e e k i n g  
The length of the withdrawal period that usually separates drug use and relapse also 
modulates the strength of drug-seeking behavior. Over the first two months of 
withdrawal, time-dependent changes in the intensity of craving and drug seeking 
accompanied by neurochemical findings have been demonstrated (see Lu et al., 2004 for 
a detailed review). Withdrawal-induced changes that are linked to glutamatergic 
neurotransmission include upregulation of AMPA and NMDA glutamate receptor 
subunits in the ventral tegmental area, amygdala, and nucleus accumbens (Carlezon and 
Nestler, 2002; Lu et al., 2003; Lu et al., 2005). Also increased expression levels of 
activator of G protein signaling 3 (AGS3) have been found in the prefrontal cortex and 
the nucleus accumbens core following 3 weeks, but not 1 or 7 days of withdrawal from 
cocaine (Bowers et al., 2004). AGS3 regulates the signaling of Gi/o-protein coupled 
receptors by inhibiting the reassociation of the two subunits (Giα and Gβγ) of the G-
protein after receptor activation. Thus, changes in AGS3 levels may alter the functioning 
of G-protein coupled dopamine and metabotropic glutamate receptors, thus affecting 
drug-seeking behavior. In drug-naïve animals, the phenotype of repeated cocaine 
treatment can be mimicked by injections of an AGS3-derived peptide. These animals 
show an enhanced locomotor response to an acute injection of cocaine (Bowers et al., 
2004), much like animals that have been repeatedly treated with cocaine (Vanderschuren 
and Kalivas, 2000). More interestingly, these animals also show an enhanced glutamate 
release in the nucleus accumbens in response to an acute injection of cocaine, and 
cocaine-induced drug seeking is potentiated (Bowers et al., 2004). Decreasing levels of 
functional AGS3 by expression of AGS3 antisense was found to block heroin and 
cocaine seeking induced by priming injections (Bowers et al., 2004; Yao et al., 2005).
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2.4.3 Additional transmitters 
In addition to dopamine and glutamate, the transmitters noradrenaline and gamma-
aminobutyric acid (GABA) as well as the endocannabinoid system contribute to modulation 
of drug-seeking behavior. Modulators of the opioidergic system such as the nonselective 
opioid antagonist naltrexone have also been studied, especially with regard to attenuation of 
opiate- and alcohol-seeking behavior (see e.g. Lê and Shaham, 2002; O'Brien, 2005). 
Noradrenaline participates extensively in the modulation of stress-induced relapse. 
Footshock stress has been shown to increase noradrenaline levels in the prefrontal 
cortex, amygdala, and bed nucleus of the stria terminalis (Erb et al., 2000; Morilak et al., 
2005). Noradrenergic receptors, called adrenoceptors, are divided into ? and ? receptors 
with the subtypes ?1, ?2, and ?1-3. ?2 antagonists, which stimulate noradrenaline release, 
are capable of inducing relapse (Lee et al., 2004; Shepard et al., 2004), whereas ?2
agonists (which decrease noradrenaline release) have been shown to attenuate stress-
induced heroin and cocaine seeking (Erb et al., 2000; Shaham et al., 2000). Also ?-
adrenergic antagonists attenuate stress-induced drug seeking (Leri et al., 2002). In 
contrast, drug priming is seldom affected by treatment with noradrenergic agonists or 
antagonists (Erb et al., 2000; Leri et al., 2002; but see Zhang and Kosten, 2005). 
The GABA agonists baclofen and muscimol have been widely used in reinstatement 
studies to inactivate brain regions (see e.g. McFarland and Kalivas, 2001; Fuchs et al., 
2004). However, GABA agonists have been found to reduce drug-seeking behavior also 
after systemic administration (Johnson et al., 2005). Cue-induced nicotine, heroin, and 
cocaine seeking as well as priming dose -induced cocaine seeking were decreased by 
baclofen or another GABA agonist, CGP44532 (Campbell et al., 1999; Di Ciano and 
Everitt, 2003; Paterson et al., 2005). Baclofen has been tested also in clinical trials, 
where it has reduced craving for alcohol and cocaine as well as increased abstinence 
days (see O'Brien and Gardner, 2005), suggesting that GABA agonism may be effective 
in the treatment of drug addiction. GABA agonists of the benzodiazepine class are 
currently used for the treatment of acute alcohol withdrawal and symptoms secondary to 
alcohol dependence, including anxiety (Lejoyeux et al., 1998).  
Endocannabinoids function as retrograde signaling messengers and modulators of 
synaptic transmission. Cannabinoid agonists are capable of inducing relapse of heroin, 
alcohol, cocaine, and cannabinoid seeking (De Vries et al., 2002; Fattore et al., 2003; De 
Vries et al., 2003; Spano et al., 2004; McGregor et al., 2005). Recently, cannabinoid 
antagonists have received a lot of attention in drug seeking studies. The CB1 receptor 
antagonist rimonabant (SR-141716A) has been reported to decrease cue-induced alcohol, 
nicotine, methamphetamine, and heroin seeking (Anggadiredja et al., 2004; Cippitelli et 
al., 2005; De Vries et al., 2005; Economidou et al., 2006) and priming dose -induced 
cannabinoid, methamphetamine, and heroin seeking (De Vries et al., 2003; Spano et al., 
2004; Anggadiredja et al., 2004; Fattore et al., 2005). Rimonabant has been tested in 
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clinical trials with promising results for smoking cessation and the treatment of obesity 
(Gadde, 2005; Pi-Sunyer et al., 2006; Maldonado et al., 2006). 
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3 AIMS OF THE STUDY 
Relapse is a major problem in the treatment of drug addiction. Dopamine and glutamate 
are suggested to be the main neurotransmitters involved in mediating the effects of drug re-
exposure and drug-associated stimuli on drug-seeking behavior. Research has, however, 
largely concentrated on dopamine, and the role of glutamate has until recently received 
relatively little attention. Existing data suggests that drug-seeking behavior can be 
attenuated by dampening glutamatergic neurotransmission, but the role of different 
glutamate receptor subtypes in relapse induced by drug-associated cues has so far not been 
systematically explored. Also, it should be clarified whether the effects of glutamate 
transmission on drug seeking are universal or specific to a certain drug or drug group. 
The specific aims of the present study were:  
I  To examine the role of glutamate receptor subtypes in cue-induced drug-seeking 
behavior using animal models 
II To examine whether glutamate receptor antagonism similarly modulates 
alcohol- and cocaine-seeking behavior  
III To examine, using glutamate receptor antagonists, whether glutamatergic 
neurotransmission in the nucleus accumbens is involved in cue-induced 
reinstatement of drug seeking 
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4 MATERIALS AND METHODS 
4.1 Animals
Male Wistar rats (HsdCpb:Wu, Harlan, The Netherlands, or Martinsread, Germany) were 
used in the cocaine seeking and alcohol deprivation studies and male Long-Evans rats 
(HsdBlu:LE, Harlan Sprague Dawley, Indianapolis, USA) in the alcohol reinstatement 
studies. Rats weighed 160-180 g upon arrival to the animal facilities and were allowed an 
acclimatization period of at least 1 week prior to the experiments. The rats were housed in 
pairs in Eurostandard Type IV cages (transparent polycarbonate, dimensions 595 x 380 x 
200 mm) in a temperature and humidity controlled room under a reversed 12-h light-dark 
cycle. Water and pellet food (RM1, SDS, Witham, UK) were available ad libitum in the 
home cage unless otherwise stated (see subsequent description). Behavioral testing was 
conducted during the dark phase of the light-dark cycle. All experimental procedures using 
animals were carried out under the National Animal Welfare Act and were approved by the 
Institutional Animal Care and Use Committee at the National Public Health Institute and 
the Chief Veterinarian of the County Administrative Board. 
4.2 Drugs 
Cocaine hydrochloride was obtained from the University Pharmacy (Helsinki, Finland) 
and dissolved in sterile 0.9% physiological saline. In the alcohol seeking studies, the 
10% w/v alcohol solution was diluted from 94% w/v ethanol (Berner Oy, Helsinki, 
Finland) with tap water. MK-801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] 
cyclohepten-5,10-imine hydrogen maleate],  CGP39551 [DL-(E)-2-amino-4-methyl-5-
phosphono-3-pentanoic acid carboxyethylester], D-AP5 [D-(-)-2-Amino-5-
phosphonopentanoic acid], CNQX (6-cyano-7-nitroquinoxaline-2,3-dione disodium),   
NBQX (2,3-Dioxo-6-nitro-1,2,3,4-tetra-hydrobenzo[f]quinoxaline-7-sulfonamide), (S)-
3,4-DCPG [(S)-3,4-dicarboxyphenylglycine], and  MPEP [2-methyl-6-(phenylethynyl) 
pyridine hydrochloride] were obtained from Tocris Cookson Ltd. (Bristol, UK). 
LY379268 [(-)-2-oxa-4-aminobicyclohexane-4,6-dicarboxylic acid] was a generous gift 
from Eli Lilly & Co. MK-801, CGP39551, (S)-3,4-DCPG, and LY379268 were 
dissolved in saline. CNQX and NBQX were dissolved in distilled water. L-701,324 and 
MPEP were suspended in propylene glycol, Tween 80, and saline (ratio 1:1:18). All 
systemically administered drugs were injected intraperitoneally (ip) in a volume of 1 
ml/kg. For intracranial injections, CNQX, D-AP5, and MPEP were dissolved in sterile 
saline and administered in a volume of 0.5 μl/side. 
4.3 Surgery and intracranial injections 
Animals in the cocaine seeking studies (I, V, VI) were implanted with chronic jugular 
catheters  under isoflurane anaesthesia. The catheter assembly was made in-house and 
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consisted of a 13-cm length of silastic tubing (inside diameter 0.31 mm; outside diameter 
0.64 mm), attached to a guide cannula that was bent at a right angle. The cannula was 
embedded into a dental cement base and anchored with surgical polypropylene mesh. 
The catheters were implanted with the proximal end reaching the heart through the right 
jugular vein, continuing subcutaneously over the shoulder, and exiting between the 
scapulae. After surgery, catheters were flushed once a day for the next 10 days with a 
0.05 ml infusion of an antibiotic (Oriprim, Orion Pharma, Espoo, Finland) to prevent 
infection and a 0.1 ml infusion of 0.9% saline containing heparin (30 IU/ml). Thereafter, 
the catheters were flushed daily with heparinized saline at the end of each self-
administration session. If an abrupt increase or decrease was observed in the number of 
cocaine infusions earned by an individual animal during the session, catheter patency 
was tested by infusing the short-acting anesthetic methohexital (Brevimytal Natrium, 
Lilly Deutschland GmbH, Giessen, Germany) through the catheter. Animals with patent 
catheters exhibited a rapid loss of muscle tone within 2 s of the methohexital infusion. 
Rats receiving intracranial injections (study VI) were implanted with bilateral 23 gauge 
stainless steel guide cannulas (10 mm in length) aimed at the nucleus accumbens core 
[anteroposterior +1.9 mm, mediolateral ±1.8 mm relative to bregma, dorsoventral –5.2 
mm from the skull surface, coordinates according to Paxinos and Watson (1997)] under 
halothane anaesthesia. Cannulas were fastened to the skull with three stainless steel 
screws and dental cement and sealed with stylet wires (30 gauge) to prevent occlusion.  
Rats were allowed at least one week of recovery from surgery before behavioral training 
and testing was continued. 
Intra-accumbal injections were given through 30 gauge injector cannulas connected to 
10 μl Hamilton syringes via polyethylene tubing. The injectors extended 2 mm below 
the guides. Injections were delivered in a volume of 0.5 μl/side over a period of 90 sec 
with a Razel infusion pump (Model A-99, Razel Scientific Instruments, Inc., Stamford, 
CT, USA) 15 min before behavioral testing. After the injections, the injectors were left 
in place for a 45-sec diffusion time. Animals were gently hand-held during the injections 
and were habituated to the procedure before testing. After completion of the 
experiments, rats were anesthetized, decapitated, and the brains were removed and stored 
in formaline. Coronal sections were sliced on a cryostat and stained with thionin for 
examination of injector tip locations. 
4.4 Cocaine seeking studies (I, V, VI) 
4.4.1 Apparatus 
Experiments took place in operant chambers (Model ENV-112B, MED Associates, 
Georgia, VT, USA) enclosed in ventilated sound-attenuating cubicles. The chambers 
were equipped with a food hopper in the middle of the front panel. A food dispenser 
located behind the front panel delivered 45 mg Noyes pellets to the food hopper. Two 
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retractable levers were located on both sides of the food hopper. A white stimulus light 
was mounted above each lever and auditory stimuli were delivered from a speaker 
positioned on the front panel. Intravenous infusions were delivered at the volume of 0.1 
ml by means of activating an infusion pump outside the sound-attenuating cubicle. The 
infusion pump was attached to a counterbalanced liquid swivel with Tygon tubing. From 
the swivel, Tygon tubing protected by a steel spring passed through a hole in the operant 
chamber and was connected to the catheter base at the midscapular region of the animal. 
Schedule contingencies and data collection were controlled by a computer using MED-
PC behavioral software (MED Associates). 
4.4.2 Food training 
To facilitate acquisition of cocaine self-administration, rats were trained to lever press 
for food reinforcement before they were implanted with iv catheters. During training 
rats were restricted to 4 g of standard pellet food per day and trained under a fixed ratio 1 
(FR1) schedule with a time-out (TO) duration of 1 s on both response levers. A lever 
press response resulted in the delivery of a 45 mg Noyes pellet (Formula “A/I”, Research 
Diets Inc., New Brunswick, NJ, USA). Rats were trained during daily 60 min sessions 
until they earned 100 pellets during the session. Once rats had reached this criterion (2–4 
sessions), they were returned to ad libitum food and implanted with iv catheters.  
4.4.3 Cocaine seeking under a second-order schedule of self-administration (Study I) 
One week after implantation of jugular catheters, rats were allowed to respond for a 0.1 
ml intravenous infusion of cocaine (0.25 mg/infusion, dissolved in 0.9% physiological 
saline) under an FR1 TO 20-s schedule during daily 2-h sessions.  At the beginning of 
each session, the house light was turned off and the two response levers were extended.  
Responding on the active lever resulted in an infusion that was signalled by a 20-s 
illumination of the stimulus light and a 3.5-s tone. Responses on the inactive lever were 
recorded but had no programmed consequences.  Once animals had acquired reliable 
responding under the FR1 TO 20-s schedule, a second-order schedule of reinforcement 
of the type FRx(FRy:S) was introduced, where x was the number of  conditioned 
stimulus (CS) presentations (1-s stimulus light and tone) required for the delivery of a 
cocaine infusion and y was the number of lever presses required for a CS presentation. 
Therefore, rats were presented a 1-s stimulus light and tone after y responses, and a 20-s 
stimulus light and a 3.5-s tone after completion of x, i.e., during each cocaine infusion. 
The schedule requirements were gradually increased as follows: FR1(FR2:S), 
FR1(FR3:S), FR1(FR5:S), FR1(FR7:S), FR2(FR5:S), FR3(FR5:S), FR4(FR5:S), 
FR5(FR7:S). When rats had reached the FR5(FR7:S) schedule or self-administered less 
than 10 infusions during the 2-h session, a second-order schedule consisting of two fixed 
intervals (FI) followed by a 2-hour period of self-administration under FR4(FR7:S) was 
introduced. The length of the fixed interval was gradually increased from 5 to 15 
minutes.  Thus, under the final reinforcement schedule, rats were allowed to respond for 
the first two cocaine infusions under an FI15min(FR7:S) schedule, and then take an 
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unlimited number of cocaine infusions under an FR4(FR7:S) schedule for 2 hours. The 
first interval measured drug seeking in the undrugged state whereas the second interval 
measured drug seeking under the influence of cocaine. The purpose of the latter schedule 
was to strengthen action-outcome associations and the importance of the CS in the 
maintenance of cocaine responding as well as measure cocaine taking. When rats had 
reached this schedule, the cocaine unit dose was increased to 0.5 mg/infusion as this 
dose results in higher response rates during the fixed interval component of the schedule. 
The effects of the AMPA/kainate antagonist CNQX (0, 0.75, 1.5, 3 mg/kg ip, n = 11) 
administered in a within-subjects, Latin-square design 20 minutes before self-
administration sessions on responding for cocaine were examined.  
4.4.4 Cue-induced reinstatement of cocaine seeking (Studies V and VI) 
The experiment consisted of three phases: conditioning, extinction, and reinstatement. As 
in study I, rats were allowed to respond for a 0.1 ml infusion of cocaine (0.25 mg/infusion, 
dissolved in 0.9% physiological saline) under an FR1 TO 20-s schedule during daily 2-h 
sessions.  Once animals had acquired reliable responding under the FR1 TO 20-s schedule, 
a second-order schedule of reinforcement of the type FRx(FRy:S) was introduced, where x 
was the number of  CS presentations (1-s stimulus light and tone) required for the delivery 
of a cocaine infusion and y was the number of lever presses required for a CS presentation. 
The schedule requirements were gradually increased as follows: FR1(FR2:S), FR1(FR3:S), 
FR1(FR5:S), FR1(FR7:S), FR2(FR5:S), FR3(FR5:S), FR4(FR5:S).  
Extinction training began after 4 to 6 days of cocaine self-administration under the 
FR4(FR5:S) schedule. During the extinction phase, responding had no programmed 
consequences. Extinction sessions continued until no further trend for either increased or 
decreased responding was seen in the group mean for at least 5 consecutive sessions. 
Reinstatement testing began on day 1 post-extinction. During the first minute of a 
reinstatement session the cocaine-associated light and auditory stimuli were presented 6 
times non-contingently (once every 10 seconds). Then the response levers were extended 
into the self-administration chamber and the cocaine-associated stimulus complex was 
contingently available under the FR4(FR5:S) schedule that was used during the 
conditioning phase, but no cocaine was available. Reinstatement sessions were 
conducted twice a week with the rats remaining in their home cages on intervening days. 
In order to exclude the possibility that responding during reinstatement sessions was 
induced by the intermittent testing schedule and not by presentations of the cocaine-
associated stimulus, a group of rats (n = 7) with reliable reinstatement baselines was tested 
during seven consecutive twice-a-week reinstatement sessions under extinction conditions.  
The effects of the competitive NMDA antagonist CGP 39551 (0, 2.5, 5, 10 mg/kg, n =
8), the NMDA/glycine antagonist L-701,324 (0, 0.63, 1.25, 2.5 mg/kg, n = 10), the 
AMPA/kainate antagonists CNQX (0, 0.75, 1.5, 3 mg/kg, n = 8) and NBQX (0, 1.25, 
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2.5, 5 mg/kg, n = 7), and the mGluR5 antagonist MPEP (0, 1.25, 2.5, 5 mg/kg, n = 10) 
on cue-induced reinstatement of cocaine seeking were examined. The drugs were 
administered intraperitoneally 20 minutes before behavioral testing in a within-subjects 
Latin-square design. 
To examine the involvement of the nucleus accumbens in cue-induced cocaine seeking, 
the effects of the AMPA/kainate antagonist CNQX (0, 0.01, 0.03 μg/side, n = 6), the 
competitive NMDA antagonist D-AP5 (0, 1, 2 μg/side, n = 8), and the mGluR5 
antagonist MPEP (0, 0.5, 1 μg/side, n = 9) administered into the accumbens core on 
reinstatement responding were examined. The antagonists were administered 15 minutes 
before testing in a within-subject, Latin-square design. Responding was allowed to 
return to baseline levels between injections. 
4.5 Alcohol seeking studies (II, III, IV) 
4.5.1 Apparatus 
All operant sessions took place in operant chambers (Lafayette Instrument, Lafayette, IN) 
enclosed in ventilated sound-attenuating cubicles. The front panel of each chamber was 
equipped with two response levers and two drinking cups between the levers. A blue stimulus 
light was mounted above the right response lever. Auditory stimuli (2.9 kHz, 65 dB) were 
delivered from a loudspeaker positioned on top of the self-administration chamber. 
Responses at the appropriate lever activated a syringe pump that delivered a 0.1-ml drop of 
fluid to one of the two drinking cups. MED-PC behavioral software (MED Associates Inc., 
Georgia, VT) was used for controlling the operant chambers and collecting data. 
4.5.2  Operant alcohol self-administration training 
Rats were trained to orally self-administer ethanol by using a modification of a training 
protocol described previously by Samson (1986). Briefly, rats were deprived of water for 
12 h prior to training sessions for three consecutive days and were trained to respond for 
a 0.1-ml drop of 0.2% (w/v) saccharin solution on both levers under a fixed ratio 1 (FR1) 
schedule of reinforcement. After this initial training, water deprivation was terminated, 
and animals had free access to food and water in their home cages throughout the 
subsequent training and testing. Non-deprived rats were given two additional saccharin 
sessions to confirm that they had acquired responding for saccharin before ethanol self-
administration training started. Then, during the next three sessions, responses at the 
right lever resulted in the delivery of 0.1 ml of 5% (w/v) ethanol + 0.2% saccharin 
solution. Responses at the left lever were recorded but had no programmed 
consequences. Thereafter, the concentration of ethanol was increased first to 8% and 
then to 10% w/v and the concentration of saccharin was decreased until saccharin was 
eliminated completely from the drinking solution. 
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4.5.3 Operant alcohol self-administration (Study IV) 
The final schedule of reinforcement for the 10% w/v ethanol concentration was similar to 
the training schedule except that a stimulus light was added. Thus, during the 30-min 
sessions responses on the active lever resulted in the delivery of 0.1 ml of ethanol and, in 
addition, in the illumination of the stimulus light for 3 s. The left lever remained inactive. 
When rats had reached stable ethanol self-administration under these conditions, the 
effects of the mGlu2/3 receptor agonist LY379268 (0, 1, 3, 5 mg/kg ip, n = 10) and the 
mGlu8 receptor agonist (S)-3,4-DCPG (0, 5, 10, 15 mg/kg ip, n = 8) on ethanol self-
administration were examined in a Latin-square, within-subjects design. The agonists 
were administered 30 min (LY379268) or 15 min [(S)-3,4-DCPG] before start of the 
self-administration session.  
4.5.4 Cue-induced reinstatement of alcohol seeking (Studies II, III and IV) 
During the conditioning phase, rats self-administered 10 % w/v alcohol and 80 μM
quinine hydrochloride during 30-min sessions on semi-randomly alternating days.  
Olfactory discriminative stimuli (SD) predicting alcohol or quinine availability were 
presented during the sessions. Alcohol availability (S+) was signaled by anise odor 
(trans-anethole, Sigma-Aldrich Chemie GmbH, Steinheim, Germany), whereas quinine 
availability (i.e. non-reward) was signaled by citrus odor [S-, (R)-(+)-limonene, Sigma-
Aldrich Chemie GmbH, Steinheim, Germany]. The olfactory stimuli were generated by 
placing a small piece of absorbent paper containing a drop of either anethole or limonene 
next to the self-administration chamber inside the sound-attenuation cubicle immediately 
before the start of the session. In addition to these discriminative stimuli, each alcohol 
delivery was accompanied by a 3-s light stimulus (CS+), while a 3-s auditory stimulus 
(CS-) was presented with quinine delivery. During the first week of the 7-week 
conditioning phase rats were given alcohol sessions only. Thereafter, alcohol and 
quinine sessions were given in a semi-random order until rats received a total of 18 
alcohol and 17 quinine sessions. 
The conditioning phase was followed by extinction training. During 30-min extinction 
sessions, responding had no programmed consequences, the olfactory stimuli signaling 
alcohol or quinine availability were withheld, and the liquid delivery lines remained 
empty. Extinction sessions continued until no further trend for either increased or 
decreased responding was seen in the group mean for at least five consecutive sessions. 
Reinstatement sessions began on day 1 post-extinction. During the first session, rats 
were presented with the SD predictive of alcohol non-availability (i.e. quinine 
availability, citrus odor), and responses on the previously active lever resulted in a 3-s 
presentation of the auditory stimulus (CS-) and activation of the syringe pump motor, but 
not in the delivery of any drinking solution. During the next two sessions rats were 
tested for alcohol seeking under two conditions: with the alcohol-associated stimuli 
(S+/CS+) present and with the alcohol-associated stimuli accompanied by a response-
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contingent 0.2 ml priming dose of 10% w/v alcohol (S+/CS+/priming). Both sessions 
started with the presentation of the alcohol-associated SD (anise odor) and active lever 
responses turned on the syringe pump motor and the alcohol-associated CS+, the 3-s 
light. In addition, during the alcohol priming sessions, the first two lever responses 
produced 0.1 ml of alcohol solution to the drinking cup. This provided rats with two 
additional stimuli, namely the taste and smell of ethanol that had been present during the 
conditioning, but not the extinction phase. Half of the rats were tested under the S+/CS+
condition on day 2 postextinction and the S+/CS+/priming condition on day 5 
postextinction. On intervening days rats remained in their home cages. The conditions 
were reversed for the other half of the animals. Thereafter, reinstatement sessions were 
conducted twice a week (on Tuesdays and Fridays) under the S+/CS+/priming condition. 
The rats remained in their home cages on intervening days.  
The effects of the uncompetitive NMDA receptor antagonist MK-801 (0, 0.5, 0.15 
mg/kg i.p., n = 10), the competitive NMDA antagonist CGP39551 (0, 5, 10 mg/kg i.p., n
= 8), the NMDA/glycine antagonist L-701,324 (0, 2, 4 mg/kg i.p., n = 9), the 
AMPA/kainate antagonist CNQX (0, 0.5, 1.5 mg/kg i.p., n = 10), the mGluR5 antagonist 
MPEP (0, 1, 3, 10 mg/kg i.p.,  n = 10), the mGluR2/3 agonist LY379268 (0, 1, 3, 5 
mg/kg i.p., n = 12), and the mGluR8 agonist (S)-3,4-DCPG (0, 5, 10, 15 mg/kg i.p., n =
9) on alcohol-seeking behavior were examined in a Latin-square, within-subjects design 
under the S+/CS+/priming condition described above. The pretreatment times were 30 
min for MPEP and LY379268, 20 min for MK-801, CGP39551, L-701,324 and CNQX, 
and 15 min for (S)-3,4-DCPG. On the reinstatement session preceding the first drug 
pretreatment session rats were administered a saline injection (1 ml/kg i.p.) 15-30 min 
before testing to habituate them to the injection procedure. 
4.5.5 Alcohol relapse measured by the alcohol deprivation effect (Study II) 
Rats in the alcohol deprivation experiments were given ad libitum access to tap water, 5%, 
10%, and 20% (v/v) alcohol in their home cages. The positions of the water and alcohol 
bottles were changed weekly to avoid location preferences. After 8 weeks of continuous 
alcohol access, a schedule of 4 weeks of alcohol access followed by two weeks alcohol 
non-access (deprivation) was introduced. On the last three days of alcohol access, the 
bottles and rats were weighed daily for the calculation of alcohol and water consumption. 
At the beginning of the deprivation phase all alcohol bottles were removed from the cages 
leaving the animals with only water and food. After 14 days, the alcohol solutions were 
returned to the animals and the bottles and rats were again weighed daily for 4 days. 
The effects of MPEP on alcohol drinking and deprivation were measured in rats with 12 
months of experience of repeated cycles of alcohol access and deprivation. For 
evaluating the effects of MPEP on baseline drinking rats were divided into three groups 
(n = 10) and administered MPEP (0, 3 or 10 mg/kg ip) for three subsequent days before 
the alcohol deprivation phase. The effects of MPEP on the alcohol deprivation effect 
were examined in rats injected with MPEP on the last two days of the alcohol 
deprivation period as well as during the first day of alcohol re-access. To ensure that 
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previous MPEP treatment during baseline drinking did not influence measurements of 
the alcohol deprivation effect different groups received different treatments during 
baseline and alcohol deprivation drinking. 
4.6 Sucrose self-administration (Study VI)  
In order to assess the effects of intra-accumbally administered glutamate receptor 
antagonists on the ability to lever-press and also to determine whether the antagonists 
attenuate responding for a non-drug reinforcer, a group of rats was trained to self-
administer 45-mg sucrose pellets (Noyes precision pellets PJFSC-0045, Research Diets 
Inc., New Brunswick, NJ, USA). Initially, rats were trained during 2-h sessions under an 
FR1 schedule on the right lever. Responding on the left lever had no programmed 
consequences. The response requirement was then increased to FR2, FR3, and FR5. 
Thereafter, a variable interval 30 s (VI30s) schedule followed by a VI60s schedule was 
introduced.  No stimuli were associated with the delivery of pellets. The VI60s schedule 
was chosen because under it rats displayed similar sustained responding throughout the 
2-hour session as seen during reinstatement sessions.  When responding had stabilized 
under the VI60s schedule (i.e. the number of responses varied less than 20% and the 
number of pellets earned varied less than 10% over three days) rats were administered 
CNQX (0, 0.03 μg/side, n = 8), D-AP5 (0, 2 μg/side, n = 7), or MPEP (0, 0.5, 1 μg/side, 
n = 6) into the nucleus accumbens core 15 minutes before testing in a within-subjects, 
Latin square design. The effects of CNQX and D-AP5 were tested in the same group of 
rats (n = 8) in a within-subjects, Latin-square design, while MPEP was tested in a 
separate group (n = 6) because previous reinstatement tests had indicated possible 
conditioned aversive effects of MPEP. Responding was always allowed to return to 
baseline levels and stabilize between injections. 
4.7 Locomotor activity (Studies I-VI) 
As a separate control experiment, spontaneous locomotor activity was measured after 
pretreatment with glutamate receptor agonists and antagonists. This was to clarify 
whether the observed changes in operant responding were caused by effects on motor 
performance, e.g. drug-induced sedation. 
Locomotor activity was measured in transparent Eurostandard Type III cages 
(transparent polycarbonate, dimensions 43 x 27 x 19 cm) that were placed inside 
photocell frames (Cage Rack Activity System, San Diego Instruments, CA, USA). The 
frames were equipped with seven pairs of photocells (5 cm off the cage floor) for 
measuring horizontal activity and eight pairs of photocells (12 cm off the floor) for 
measuring vertical activity. The number of photocell interruptions was recorded by a 
computer at 5-min intervals for 2 hours. During the first three sessions, rats were 
habituated to the test cages, and, on the third day, also administered with a habituation 
saline injection. Thereafter, rats were injected intraperitoneally with CGP39551 (0, 2.5, 
5, 10 mg/kg), L-701,324 (0, 0.63, 1.25, 2.5 mg/kg), CNQX (0, 0.75, 1.5, 3 mg/kg), 
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NBQX (0, 1.25, 2.5, 5 mg/kg) or MPEP (0, 1.25, 2.5, 5 mg/kg) or intra-accumbally with 
CNQX (0, 0.03 μg/side), D-AP5 (0, 2 μg/side), or MPEP (0, 0.5, 1 μg/side) in a within-
subjects Latin-square design 15-30 minutes before testing (n = 8 for each antagonist).  
4.8 Statistical analysis 
The effects of the glutamate receptor agonists and antagonists on alcohol and cocaine 
seeking, locomotor activity, and sucrose self-administration were analyzed with a within-
subjects one-way analysis of variance (ANOVA) with repeated measures on dose. 
Following a significant main effect of dose, each individual drug dose was compared with 
the vehicle condition using a post hoc means comparison with Bonferroni correction. In the 
reinstatement experiments, paired t tests were used for demonstrating reinstatement of 
responding compared with the extinction baseline and for testing the stability of 
responding by comparing the vehicle injection with non-injection baseline sessions.  
In the alcohol deprivation experiment, treatment effects on postabstinence days were 
analyzed with a two-way ANOVA with repeated measures (treatment x days). For post 
hoc comparisons, a Newman-Keuls test was applied when appropriate. 
In all statistical analyses, criterion for significance was set at the 0.05 level. 
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5 RESULTS
5.1 Reinstatement of cocaine-seeking behavior by cocaine-associated cues 
During the last three conditioning (cocaine self-administration) sessions of the 
experiment, the mean (±SEM) numbers of responses on the active and inactive lever, 
respectively, were 409.0±29.4 and 10.0±7.0 (Study IV). Following extinction training, 
responding decreased to a level of 14.8±1.3 on the previously active and 4.7±0.8 on the 
previously inactive lever. Re-introduction of the cocaine-associated stimulus complex 
reinstated responding on the active lever (p<0.05 compared to extinction baseline) and 
maintained responding reliably during repeated test sessions conducted twice a week 
(Figure 1). When the cocaine-associated stimulus complex was omitted in a separate 
group of rats, responding decreased rapidly towards extinction levels (p<0.0001) 
showing that responding was maintained by the cocaine-associated stimulus complex 
and not the intermittent testing pattern (Figure 2).  
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Figure 1. Conditioning, extinction, and reinstatement phases during the cocaine reinstatement 
experiment (n = 15). The mean (±SEM) number of responses on the active lever is shown. 
For the conditioning and extinction phases, the last four and three days of responding are 
shown, respectively. Re-introduction of the cocaine-associated stimulus complex reinstated 
and maintained responding above extinction levels throughout the 15-day testing period. 
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Figure 2. Effects of omission of the cocaine-associated conditioned stimulus on reinstatement of 
cocaine seeking (n =7) . Shown is the mean (±SEM) number of responses on the active 
lever during the reinstatement baseline (“Reinst”; stimulus complex available response-
contingently) and seven consecutive extinction sessions (stimulus complex omitted) 
conducted every second or third day. * p < 0.05, significantly different from the 
reinstatement baseline. 
5.2 Reinstatement of alcohol-seeking behavior by alcohol-associated cues 
During the conditioning phase of the experiment, rats developed stable responding for 
alcohol and quinine. The average number of alcohol responses was, depending on study, 
from 26.2±1.2 to 32.0±3.6 on the active lever and from 2.3±0.4 to 6.4±1.7 on the 
inactive lever, whereas quinine responses ranged from 9.6±0.6 to 11.9±2.0 responses on 
the active lever and from 4.5±0.7 to 9.9±2.2 on the inactive lever. Thus, rats 
discriminated well between alcohol and quinine. The average ethanol intake was 0.53-
0.64 g/kg per session. 
During the extinction phase responding decreased to a low level (from 4.8±0.5 to 6.3±0.7 
responses on the previously active lever and from 2.5±0.3 to 4.6±0.6 responses on the 
previously inactive lever). During the alcohol reinstatement sessions, the alcohol-
associated stimuli (S+/CS+) reinstated responding on the active lever (p<0.05 compared to 
last three extinction sessions), whereas the quinine-associated stimuli (S-/CS-) decreased 
responding below extinction levels (Figure 3). Responding during the reinstatement 
session that included the small (0.2 ml) response-contingent priming dose of 10% w/v 
alcohol was significantly higher compared to the session with alcohol-associated stimuli 
alone (Figure 3). The 0.2 ml alcohol priming resulted in an average alcohol dose of 0.03 
g/kg, which all rats consumed during the session. Inactive lever responding did not differ 
from extinction levels under any of the reinstatement conditions.  
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Figure 3. Left: Lever-press responses on the active lever during 30-min conditioning and extinction 
sessions (n = 24, Study II). For the conditioning sessions, the mean (±SEM) number of 
responses averaged over the last three self-administration sessions is shown. Extinction 
responses represent the mean (±SEM) number of responses during each successive 
extinction session. Inactive lever responses have been omitted for clarity. Right: Mean 
(±SEM) number of responses during the last three extinction sessions (Ext BL), the 
reinstatement session with stimuli previously associated with nonreward, i.e. quinine (S-
/CS-), and the alcohol reinstatement sessions during which the rats were reintroduced to 
either the alcohol-associated stimuli alone (S+/CS+) or the alcohol-associated stimuli 
together with a priming dose of alcohol (S+/CS++priming).    * p < 0.05, significantly 
different from extinction baseline. 
5.3 Effects of systemic ionotropic glutamate receptor antagonism on drug 
seeking
5.3.1 Reinstatement of cocaine seeking (Study V) 
Cue-induced reinstatement of cocaine seeking was attenuated by systemic administration 
of the NMDA/glycine antagonist L-701,324 and the AMPA/kainate antagonists CNQX 
and NBQX (p´s<0.01). The competitive NMDA antagonist CGP39551 failed to alter 
reinstatement responding. Inactive lever responding was not affected by the 
pretreatments (Figure 4). 
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Figure 4. Effects of pretreatment with the ionotropic glutamate receptor antagonists CGP39551 (n = 
8), L-701,324 (n = 10), CNQX ( n = 8), and NBQX (n = 7) on cue-induced reinstatement of 
cocaine-seeking behavior during the 2-h session. Responses are expressed as the 
percentage (mean ± SEM) of the mean number of responses during three vehicle injection 
sessions that preceded the drug pretreatment sessions. *  p < 0.05, significantly different 
from vehicle following a significant main effect of dose in ANOVA. 
5.3.2 Cocaine seeking under a second-order schedule of reinforcement (Study I) 
The AMPA/kainate antagonist CNQX suppressed cocaine seeking during the first 
interval of the fixed interval, second-order schedule of self-administration (p<0.001), but 
did not alter responding during the second interval, or the number of cocaine infusions 
during the latter part of the session under the FR4(FR7:S) schedule. Inactive lever 
responding was not affected (Figure 5). 
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Figure 5. Effects of pretreatment with the AMPA/kainate antagonist CNQX (n = 10) on cocaine 
seeking under a second-order schedule of reinforcement. Shown is the mean (± SEM) 
number of responses during the first 15-minute interval measuring cocaine seeking in the 
undrugged state and the second 15-minute interval measuring cocaine seeking under the 
influence of the drug. For the 2-hour period, during which cocaine was freely available 
under an FR4(FR7:S) schedule, the mean (± SEM) number of cocaine infusions is shown. 
* p < 0.05, significantly different from vehicle following a significant main effect of dose in 
ANOVA. 
5.3.3 Reinstatement of alcohol seeking (Study III) 
Administration of the NMDA/glycine antagonist L-701,324 (p<0.05) and the 
AMPA/kainate antagonist CNQX (p<0.05) decreased reinstatement induced by the 
alcohol-associated stimuli. The competitive NMDA antagonist CGP39551 and the 
noncompetitive NMDA antagonist MK-801 did not alter reinstatement responding (Figure 
6).  Inactive lever responding was not affected with the exception of L-701,324, which 
increased responding (p<0.05). This effect was however not detected by the post hoc test. 
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Figure 6. Effects of pretreatment with the ionotropic glutamate receptor antagonists MK-801 (n = 
10), CGP39551 (n = 8), L-701,324 (n = 9), and CNQX (n = 10) on alcohol-seeking 
behavior induced by alcohol associated stimuli (S+/CS+) and a response-contingent 0.2-ml 
alcohol priming dose. Shown is the mean (± SEM) number of responses during the 30-min 
reinstatement sessions. * p < 0.05, significantly different from vehicle following a 
significant main effect of dose in ANOVA. 
5.4 Effects of systemic metabotropic glutamate receptor agonism and 
antagonism on drug seeking 
5.4.1 Reinstatement of cocaine seeking (Study V)  
Systemic administration of the mGluR5 antagonist MPEP decreased cue-induced 
reinstatement of cocaine seeking on the active lever (p<0.001) (Figure 7). Also inactive 
lever responding was decreased (p<0.05) although the effect did not reach significance 
in the post hoc test. In addition, a decrease in responding compared to reinstatement 
55
baseline was observed after pretreatment with the saline vehicle included in the within-
subjects Latin-square injection series (p<0.05). 
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Figure 7. Effects of pretreatment with the 
mGluR5 antagonist MPEP (n = 10) on 
cue-induced reinstatement of cocaine-
seeking behavior. Shown is the mean 
(± SEM) number of responses during 
the 2-h session. * p < 0.05, 
significantly different from vehicle 
following a significant main effect of 
dose in ANOVA. 
5.4.2 Reinstatement of alcohol seeking (Studies II and IV )  
Administration of the mGluR2/3 agonist LY379268 (p<0.05) and the mGluR8 agonist 
(S)-3,4-DCPG (p<0.0001) as well as the mGluR5 antagonist MPEP (p<0.0001) 
decreased reinstatement induced by alcohol-associated stimuli (Figure 8). LY379268 and 
(S)-3,4-CDPG did not affect inactive lever responding, but with MPEP a decrease was 
observed (p<0.05). 
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Figure 8. Effects of pretreatment with the mGluR2/3 agonist LY379268 (n = 12), the mGluR8 
agonist (S)-3,4-DCPG (n = 9), and the mGluR5 antagonist MPEP (n = 10) on alcohol-
seeking behavior induced by alcohol associated stimuli (S+/CS+) and a response-contingent 
0.2-ml alcohol priming dose. Shown is the mean (± SEM) number of responses during the 
30-min reinstatement sessions. * p < 0.05, significantly different from vehicle following a 
significant main effect of dose in ANOVA. 
56
5.4.3 Alcohol deprivation effect (Study II) 
The basal alcohol intake of the rats in the alcohol deprivation experiment was 2.9±0.15 
g/kg ethanol per day. MPEP decreased basal alcohol consumption compared to the saline 
control group (p<0.05). This was however mainly due to an increase in alcohol 
consumption of the control group.  
After two weeks of abstinence (alcohol deprivation), an increase in alcohol consumption, 
characteristic to the alcohol deprivation effect, was observed (p<0.001). MPEP 
administration decreased alcohol intake (p<0.05) without any significant effect on body 
weight or water intake (Figure 9). 
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Figure 9. Effects of MPEP on baseline drinking (left) and the alcohol deprivation effect (right) (n = 
10 per group). Shown is the mean daily alcohol intake in grams of ethanol/kg bodyweight 
(±SEM). Arrows indicate MPEP injections. Measurements were taken during the last 3 
days before the 14-day alcohol deprivation (AD) period and the first 4 days after re-
introduction of alcohol. Alcohol consumption on baseline days 4-6 and postdeprivation 
days 1-3 was significantly attenuated by MPEP compared to the saline control group. 
5.4.4 Alcohol self-administration (Study IV) 
After 28 sessions of alcohol self-administration with 10% w/v ethanol rats showed an 
average (±SEM) number of 26.7±1.9 responses on the active lever and 4.2±1.5 responses 
on the inactive lever. This corresponded to an average ethanol intake of 0.59±0.04 g/kg. 
In another study with Long-Evans rats this alcohol amount was found to result in blood 
alcohol levels ranging from 3 to 43 mg/100 ml when measured immediately after alcohol 
access (Czachowski et al., 1999).  
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The mGluR2/3 agonist LY379268 and the mGluR8 agonist (S)-3,4-DCPG suppressed 
alcohol self-administration (p<0.05 and p<0.01, respectively). Inactive lever responding 
was not significantly affected by the agonists (Figure 10). 
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Figure 10.  Effects of pretreatment with the mGluR2/3 agonist LY379268 (n = 10) and the mGluR8 
agonist (S)-3,4-DCPG (n = 8) on alcohol self-administration. The mean (±SEM) number 
of responses during the 30-min self-administration sessions is shown. * p < 0.05, 
significantly different from the vehicle following a significant main effect of dose in 
ANOVA. 
5.5 Effects of intra-accumbal glutamate receptor antagonism on cocaine 
seeking (Study VI) 
Following intra-accumbal administration of the NMDA antagonist D-AP5 and the 
AMPA/kainate antagonist CNQX, responding during reinstatement sessions remained 
stable during the period of testing as confirmed by paired t tests conducted separately for 
each antagonist between the vehicle dose and the reinstatement baseline (p´s>0.05). 
With the mGluR5 antagonist MPEP, however, responding during the vehicle session was 
decreased compared to baseline reinstatement sessions (p<0.05). D-AP5 and CNQX 
(p´s<0.01), but not MPEP (p>0.05), decreased responding compared to the vehicle 
condition (Figure 11). When compared to the reinstatement baseline, responding was 
suppressed following MPEP treatment (p<0.001). None of the antagonists affected 
inactive lever responding. 
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Figure 11. Effects of intra-accumbal pretreatment with the NMDA antagonist D-AP5 (n = 8), the 
AMPA/kainate antagonist CNQX (n = 6), and the mGluR5 antagonist MPEP (n = 9) on 
cue-induced reinstatement of cocaine-seeking behavior. Shown is the mean (± SEM) 
numbers of responses  during the 2-h session. * p < 0.05, significantly different from the 
vehicle; # p < 0.05, significantly different from reinstatement baseline (BL, responding 
averaged over 3 sessions preceding any drug treatments).  
Compound Ethanol Cocaine 
 Systemic Systemic N. Acc. 
Competitive NMDA antagonist CGP39551 No effect No effect - 
Competitive NMDA antagonist D-AP5 - - ?
Noncompetitive NMDA antagonist MK-801 No effect - - 
NMDA/glycine antagonist L-701,324 ? ? - 
AMPA/kainate antagonist CNQX ? ? ?
AMPA/kainate antagonist NBQX - ? - 
mGluR5 antagonist MPEP ? ? ?
mGluR2/3 agonist LY379268 ? - - 
mGluR8 agonist (S)-3,4-DCPG ? - - 
Table 2.    Effects of glutamate receptor agonists and antagonists on alcohol and cocaine seeking 
following systemic or intra-accumbal (N.Acc.) administration. Significant decrease: ? , Not 
tested: - . 
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5.6 Spontaneous locomotor activity 
The mGluR2/3 agonist LY379268 and the mGluR8 agonist (S)-3,4-DCPG attenuated 
spontaneous locomotor activity (p´s<0.05). The NMDA/glycine antagonist L-701,324, 
the AMPA/kainate antagonists CNQX and NBQX, or the mGluR5 antagonist MPEP did 
not suppress locomotor activity after systemic administration. Similarly, the NMDA 
antagonist D-AP5, CNQX, and MPEP did not alter locomotor activity after intra-
accumbal administration. 
5.7 Sucrose self-administration 
The mean (± SEM) number of responses during a habituation saline injection session 
was 2254.64 ± 510.10 on the active and 3.43 ± 1.41 on the inactive lever. This resulted 
in the delivery of 99.36 ± 4.61 sucrose pellets. D-AP5, CNQX, or MPEP did not affect 
either active lever responding or the number of pellets earned. Inactive lever responding 
was however increased by D-AP5. 
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6 DISCUSSION 
6.1 Reinstatement of cocaine seeking by cocaine-associated cues 
In the cocaine reinstatement model used in the present study, cocaine seeking was 
induced after extinction by reintroduction of a cocaine-associated stimulus complex. 
This is in agreement with previous studies showing that cocaine-paired discrete and 
discriminative cues are capable of reinstating cocaine-seeking behavior (Meil and See, 
1996; Arroyo et al., 1998; Weiss et al., 2000; Alleweireldt et al., 2002).  
The present experiments employed a second-order schedule of reinforcement to pair a 
stimulus complex consisting of a light and a tone with cocaine during the conditioning 
phase. Compared to simple ratio schedules, second-order schedules have been suggested 
to enhance the development of associations between actions and their outcomes and 
amplify the role of conditioned stimuli in exerting control over responding (Everitt and 
Robbins, 2000). Compound stimuli were chosen, because they have been shown to result 
in more robust reinstatement than single stimuli (See et al., 1999).  
The conditioning phase was followed by extinction training, during which neither 
cocaine nor the stimulus complex were available. This resulted in a gradual decrease of 
responding to a very low level. During subsequent reinstatement sessions, noncontingent 
stimulus presentations followed by contingent access to the stimulus reinstated 
responding on the previously cocaine-paired lever. The cocaine-associated stimulus 
complex maintained responding above extinction levels during repeated reinstatement 
testing conducted twice a week. 
One concern with the present reinstatement model is that the intermittent testing pattern 
could alone have resulted in reinstatement-like responding, as extinguished lever 
pressing has been shown to recover spontaneously with time after termination of 
extinction training (See et al., 1999; Bouton, 2002; Di Ciano and Everitt, 2002). 
However, when a group of rats was tested twice a week in the absence of the cocaine-
associated stimulus complex, i.e. under extinction conditions, responding was 
significantly lower than during reinstatement sessions. This shows that responding in the 
present model was maintained by and under the control of the cocaine-associated 
stimulus complex. 
6.2 Reinstatement of alcohol seeking by alcohol-associated cues 
In the alcohol reinstatement studies a procedure with both discrete and discriminative 
stimuli, which is often utilized in alcohol seeking studies, was employed (Katner et al., 
1999; Ciccocioppo et al., 2001). During the conditioning phase, one set of stimuli was 
paired with alcohol reward and another set of stimuli with alcohol non-reward. 
Following extinction, the alcohol-associated stimuli were found to selectively induce 
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reinstatement of responding. Responding was further enhanced when the animals were 
allowed to self-administer a small amount of response-contingent alcohol at the 
beginning of the reinstatement session. This finding is in line with previous studies 
showing that responding for alcohol can be reinstated by very small alcohol amounts 
(Chiamulera et al., 1995; Bienkowski et al., 1999) 
Due to the small size of the priming dose it is unlikely that the pharmacological effects of 
alcohol contributed to reinstatement. There are, however, other reasons why the priming 
dose might have increased alcohol seeking. First, the priming dose allowed the animals to 
experience the taste and smell of alcohol. The extinction sessions had been carried out 
without alcohol access and with the fluid delivery lines of the apparatus empty, so the taste 
and smell were never extinguished. It is very likely that during conditioning sessions both 
the taste and smell of alcohol were incorporated in the compound stimulus signaling 
alcohol availability and reward. Thus, presenting the complete compound stimulus during 
reinstatement instead of only the S+ (anise odor) and CS+ (light) components might have 
produced stronger reinstatement (See et al., 1999). Second, it may be that simply the act of 
consuming a fluid contributed to reinstatement. It was shown by Bienkowski et al. (2000) 
that responding could be reinstated by presentations of a liquid dipper containing either 
alcohol or water, but not an empty dipper, suggesting that the orosensory properties of the 
fluid made available are alone capable of inducing reinstatement. In fact, we discovered 
later that the 0.2 ml alcohol priming dose used in the present study is capable of reinstating 
alcohol seeking to similar levels as the alcohol-associated stimuli (anise odor and light) 
presented alone (unpublished observation). 
6.3 Effects of systemic ionotropic glutamate receptor antagonism 
In the studies examining the effects of systemic ionotropic glutamate receptor 
antagonism on drug seeking, the NMDA/glycine antagonist L-701,324 and the 
AMPA/kainate antagonist CNQX decreased both cue-induced alcohol and cocaine 
seeking. In contrast, the competitive NMDA antagonist CGP39551 did not significantly 
affect reinstatement responding. In addition to these antagonists that were tested in both 
the cocaine and alcohol models, the AMPA/kainate antagonist NBQX was found to 
decrease cue-induced cocaine reinstatement whereas the uncompetitive NMDA 
antagonist MK-801 was ineffective in modulating alcohol reinstatement. In line with the 
findings from the reinstatement studies, cocaine seeking measured by a fixed-interval, 
second-order schedule of self-administration was also decreased by CNQX. 
None of the glutamate receptor antagonists decreased spontaneous locomotor activity in 
control experiments, suggesting that the observed attenuation in reinstatement 
responding was not due to motor suppression. Also, examination of cumulative response 
patterns showed that rats responded at a stable level throughout the session, and the 
effects of antagonist pretreatments became visible slowly during the session without 
affecting initiation of responding. These findings are in agreement with previous data 
that L-701,324, CNQX, and NBQX do not show severe impairment of locomotion in the 
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dose range used in the present study (Danysz et al., 1994; Dalia and Wallace, 1995; 
Bristow et al., 1996; Mead and Stephens, 1999). 
In the present study, alcohol- and cocaine-seeking behavior was found to be decreased 
by AMPA/kainate antagonism and NMDA antagonism of the glycine site, but not other 
binding sites of the NMDA receptor complex. Previously, systemically administered 
AMPA receptor antagonists have been found to attenuate the expression of conditioned 
and drug-related behaviors such as conditioned place preference and behavioral 
sensitization (Cervo and Samanin, 1995; Tzschentke and Schmidt, 1997; Jackson et al., 
1998; Mead and Stephens, 1998; but see Li et al., 1997; Mead and Stephens, 1999), 
whereas NMDA antagonists seem to differ in their ability to modulate these behaviors 
(Bespalov, 1996; Kotlinska and Biala, 1999; Mead and Stephens, 1999; Kotlinska and 
Biala, 2000; Papp et al., 2002; Popik et al., 2003). When administered systemically in 
reinstatement studies, the AMPA antagonist GYKI52466 has been found to reduce cue-
induced reinstatement of alcohol seeking (Sanchis-Segura et al., 2006). The 
uncompetitive NMDA antagonist memantine decreases responding for a cocaine-
associated stimulus in monkeys (Newman and Beardsley, 2006), whereas another 
uncompetitive antagonist, neramexane, produces only a nonsignificant decrease in cue-
induced alcohol seeking in rats (Bachteler et al., 2005). Further contradiction is added to 
these results by MK-801, which was found to increase responding nonselectively in an 
alcohol seeking reinstatement test (Vosler et al., 2001). Thus, the present results are in 
parallel with the above suggesting that AMPA antagonism mostly attenuates cue-
conditioned behaviors whereas NMDA antagonism shows mixed results.  
In contrast to cue-induced alcohol reinstatement, there is evidence that alcohol seeking 
measured by the alcohol deprivation effect is sensitive to NMDA antagonism regardless 
of binding site. The competitive NMDA antagonist CGP37849, the NMDA/glycine 
antagonist L-701,324, the polyamine site and NR2B subunit antagonist ifenprodil, and 
the NMDA channel blockers neramexane and memantine all suppress the alcohol 
deprivation effect (Hölter et al., 1996; Hölter et al., 2000; Vengeliene et al., 2005) 
suggesting that an inhibition of NMDA receptor function in general is sufficient for the 
reduction of alcohol seeking in the alcohol deprivation model. In addition to NMDA 
receptor antagonism, the AMPA antagonist GYKI52466 has also been found to attenuate 
the alcohol deprivation effect (Sanchis-Segura et al., 2006). The differences between the 
findings in the alcohol deprivation and reinstatement models are most likely accounted 
for by the fact that the alcohol deprivation paradigm, where alcohol consumption is a 
key factor, models different aspects of relapse behavior than the reinstatement model in 
which especially the conditioned drug responses promote relapse.  Consistent with this, 
alcohol consumption can be attenuated by NMDA receptor antagonists (Hölter et al., 
2000; McMillen et al., 2004). 
6.4 Effects of systemic metabotropic glutamate receptor antagonism 
Systemic administration of the mGluR5 antagonist MPEP decreased both cue-induced 
alcohol and cocaine seeking and also the alcohol deprivation effect. In line with previous 
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studies, spontaneous locomotor activity was not affected by pretreatment with MPEP 
(Ossowska et al., 2001; Henry et al., 2002) suggesting that motor performance of the 
animals was not severely impaired.  
Examination of response patterns of the rats after MPEP pretreatment showed that the 
initial response rates were very low. In addition, the vehicle included in the within-
subjects series of injections decreased responding compared to the reinstatement 
baseline. The same effect was seen later in the study (VI) with intra-accumbal MPEP 
administration. This observation led to the hypothesis that MPEP might have aversive 
effects that became associated with the injection procedure, leading to conditioned 
suppression by the vehicle. This seemed, at first, unlikely considering that MPEP has not 
been reported to produce either place preference or aversion when administered 
systemically to mice (Popik and Wróbel, 2002; McGeehan and Olive, 2003). However, 
two recent reports describe possible aversive effects of MPEP in rats. An elevation in 
intracranial self-stimulation thresholds was observed at MPEP doses only slightly higher 
than those used in the present study, suggesting that MPEP may induce a negative 
affective state (Harrison et al., 2002; Kenny et al., 2005). Our own experiments 
conducted after the completion of the MPEP reinstatement studies showed that 
systemically administered MPEP indeed has strong aversive effects as measured by the 
conditioned taste aversion paradigm (unpublished observation). Thus, aversive effects of 
MPEP may have contributed to decreased drug seeking. 
MPEP has been the antagonist of choice in most studies examining the involvement of 
group I metabotropic receptors in drug self-administration and drug-seeking behavior. 
MPEP has been reported to reduce cocaine, nicotine, and ethanol self-administration as 
well as cocaine and nicotine seeking induced by priming (Sharko et al., 2002; Paterson et 
al., 2003; Tessari et al., 2004; Lee et al., 2005).  In addition, and supporting the present 
findings with cocaine and alcohol, MPEP attenuates cue-induced nicotine seeking 
(Bespalov et al., 2005) as well as other conditioned drug effects, such as morphine-, 
amphetamine- and cocaine-induced place preference (Popik and Wróbel, 2002; 
McGeehan and Olive, 2003; Herzig et al., 2005). In the present study, MPEP decreased 
also relapse measured by increased alcohol consumption after a period of deprivation, an 
effect that was confirmed by a recent study (Schroeder et al., 2005), and baseline alcohol 
drinking. The latter finding is in agreement with several studies reporting a decrease in 
alcohol consumption by MPEP in either the choice or self-administration paradigm 
(McMillen et al., 2005; Olive et al., 2005; Schroeder et al., 2005). 
6.5 Effects of systemic metabotropic glutamate receptor agonism 
The mGluR2/3 agonist LY379268 and the mGluR8 agonist (S)-3,4-DCPG suppressed both 
alcohol self-administration and cue-induced alcohol seeking. The effects of the agonists 
were however found to be accompanied by motor suppression. This is in accordance with 
previous reports showing that LY379268 impairs motor performance in or near the dose 
range used in the present study (Cartmell et al., 1999; Cartmell et al., 2000), although the 
impairment may not be severe enough to fully account for the decreases in operant 
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responding (Baptista et al., 2004). Thus, although motor suppression may have contributed 
to the effects of LY379268 the possibility that the agonist could also alter the reinforcing 
properties of alcohol and the ability of alcohol-paired stimuli to reinstate alcohol-seeking 
behaviour cannot be excluded. In contrast, the effects of (S)-3,4-DCPG on locomotor 
activity were more pronounced and, in addition, cumulative response patterns of the rats 
revealed that the agonist decreased responding from the onset of the session, which can be 
interpreted as an indication of motor suppression. Intracerebroventricular administration of 
(S)-3,4-DCPG has previously been found to impair performance dose-dependently on the 
rotarod in mice (Moldrich et al., 2001), but the effects of systemic administration on motor 
functions in rats are not known.  However, our observations from the present experiments 
suggest that motor suppressant effects by (S)-3,4-DCPG may have influenced responding 
in the operant tasks. 
Drug self-administration reflects mainly the unconditioned, primary reinforcing effects of 
the drug, whereas the cue-induced reinstatement model measures the potency of alcohol-
associated environmental cues to reinstate extinguished behavior and thus represents 
conditioned drug effects.  LY379268 has previously been reported to attenuate both 
reinstatement of cue-induced cocaine seeking and cocaine self-administration (Baptista et 
al., 2004) as well as heroin seeking induced by a heroin-paired context (Bossert et al., 
2004).  The present results extend these findings to alcohol, although with some caution 
keeping the motor suppressive effects of LY379268 in mind. 
In contrast to LY379268, very little is known about the effects of (S)-3,4-DCPG on 
drug-related behaviors.  The racemic form (R,S)-3,4-DCPG has been reported to 
decrease amphetamine-induced hyperactivity in mice at doses that do not affect 
spontaneous locomotor activity (Ossowska et al., 2004). However, as the R-isomer has 
antagonistic effects at AMPA receptors (Thomas et al., 2001), it is unclear whether the 
effects were due to actions at mGlu or AMPA receptors, although a role for mGlu8 
receptor agonism was proposed (Ossowska et al., 2004).  
Group II/III agonists have been reported to decrease transmitter release presynaptically 
(Schoepp, 2001). Therefore, the effects of LY379268 and (S)-3,4-DCPG could be due to 
decreased presynaptical glutamate release in response to alcohol-associated stimuli. In 
line with this, LY379268 pretreatment has been reported to reduce enhanced glutamate 
overflow in the nucleus accumbens of amphetamine-sensitized rats (Kim et al., 2005). 
However, although re-exposure to drug-associated stimuli elevates accumbal glutamate 
levels (Hotsenpiller et al., 2001), also dopamine release has been shown to be enhanced 
following exposure to an alcohol-associated context (Katner and Weiss, 1999). As 
LY379268 attenuates also dopamine release (Kim et al., 2005) and cue-induced alcohol-
seeking behavior can be reduced by dopamine receptor antagonists (Liu and Weiss, 
2002), it is possible that LY379268 decreased alcohol seeking through both 
glutamatergic and dopaminergic mechanisms. 
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6.6 Effects of intra-accumbal glutamate receptor antagonism 
To examine the possible anatomical site of action of the glutamate antagonists, the 
NMDA antagonist D-AP5, the AMPA/kainate antagonist CNQX and the mGluR5 
antagonist MPEP were injected into the nucleus accumbens core, which has previously 
been suggested to be involved in mediating the effects of glutamate on drug seeking 
(Kalivas and McFarland, 2003). It was found that all three antagonists attenuated 
reinstatement induced by the cocaine-asociated stimulus complex without any significant 
effects on motor behavior. This is in accordance with previous findings on the enhancing 
rather than suppressing effects of intra-acumbal D-AP5 and CNQX on locomotor 
activity (David et al., 2004). Lever-pressing for sucrose pellets at response rates far 
higher than those in the reinstatement experiments was neither affected by intra-
accumbal antagonist pre-treatment showing that the rats were capable of performing the 
lever-press task after antagonist administration. 
A decrease in responding, compared to reinstatement baseline, was observed following 
MPEP administration at all doses, also the saline vehicle. The same effect was seen in 
study V after systemic administration. As responding was allowed to return to baseline 
levels between injections, residual effects of MPEP are an unlikely cause for the 
decrease, as is the composition of the vehicle (saline was used also with D-AP5 and 
CNQX). Therefore, it is possible that conditioned aversive effects of MPEP detected in a 
conditioned taste aversion study of ours (unpublished observation) contributed to the 
decrease in responding. 
There are no previous reports on the effects of intracranially administered mGluR5 
antagonists on drug-seeking behavior. With the ionotropic antagonists, the present 
finding that AMPA/kainate antagonism attenuates cue-induced drug seeking is in 
agreement with previous results (Di Ciano and Everitt, 2001). However, the attenuation 
by the NMDA antagonist D-AP5 is a new finding. Previously, NMDA antagonists have 
been ineffective at modulating drug seeking behavior when injected into the nucleus 
accumbens core or more dorsally into the striatum (Cornish and Kalivas, 2000; Di Ciano 
and Everitt, 2001; Vanderschuren et al., 2005). However, there are some differences 
between these studies and the present one making it possible that drug seeking in these 
models differs in sensitivity to NMDA antagonism. In the study by Cornish and Kalivas 
(2000), reinstatement was induced by a priming injection of cocaine, whereas in the 
present study cues were used. The study by Di Ciano and Everitt (2001) examined cue-
induced drug seeking, but using the fixed-interval second-order schedule of self-
administration after a very short withdrawal period, whereas the rats in the present study 
had been withdrawn from cocaine for several weeks before reinstatement testing. 
Following long-term withdrawal, drug-seeking behavior has been shown to be enhanced, 
and this effect is accompanied by neurochemical changes (see Lu et al., 2004 for 
review). For example, cocaine seeking has been found to  increase over a 2-month 
withdrawal period (Grimm et al., 2001) and responding for an alcohol-associated cue in 
a reinstatement test is higher on day 56 of abstinence compared to days 1 and 28 
(Bienkowski et al., 2004). One more difference between the present study and the one by 
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Di Ciano and Everitt (2001) is the schedule of reinforcement. Fixed-interval schedules, 
which were employed by Di Ciano and Everitt (2001), have been shown to promote the 
development of habitual responding, whereas ratio schedules, under which there is 
always a linear relationship between response and reward rates, do not (Coutureau and 
Killcross, 2003; Yin et al., 2006). The assumption that responding in the present study 
was not habitual is supported by the fact that it quickly decreased to extinction levels 
after omission of the cocaine-associated stimulus. 
The decrease in cocaine seeking following intra-accumbal D-AP5 administration is also 
in contradiction with some of the findings in studies III and V, as the competitive 
NMDA antagonist CGP39551 was ineffective in modulating cue-induced cocaine or 
alcohol seeking after systemic administration. This is an interesting discrepancy, the 
reason of which is however unclear, and further adds to the complexity of findings with 
NMDA antagonist. As mentioned earlier, NMDA antagonists have either decreased or 
had no effect on drug-conditioned behaviors depending on antagonist and animal model 
employed. 
6.7 Glutamatergic neurotransmission and drug seeking 
Repeated treatment of laboratory animals with cocaine has been found to decrease basal 
extracellular glutamate levels in the nucleus accumbens (Bell et al., 2000; Hotsenpiller et 
al., 2001; McFarland et al., 2003). In addition, an enhanced glutamate release upon re-
exposure to cocaine or cocaine-associated stimuli has been observed in repeatedly 
cocaine-treated, but not naive animals (Bell et al., 2000; Hotsenpiller et al., 2001). 
Against a decreased basal glutamate level this results in a very large proportional 
increase in accumbal glutamate. In contrast, re-exposure to a natural reinforcer does not 
lead to enhanced glutamate release. This was shown by McFarland et al. (2003) in a 
study where a cocaine priming injection induced cocaine seeking and elevated accumbal 
glutamate levels, whereas noncontingent delivery of food pellets reinstated food seeking 
but was without effect on glutamate levels. Glutamate levels have not been examined in 
cue-reinstatement tests, but based on the above it can be assumed that stimuli paired with 
drugs during self-administration are capable of inducing glutamate release in the nucleus 
accumbens when presented alone in reinstatement tests. 
There is evidence that the changes in accumbal glutamate transmission following 
repeated drug treatment are connected to drug-seeking behavior. Normalizing the 
decreased basal glutamate levels was found to prevent the enhanced glutamate release 
induced by a cocaine priming injection and, more importantly, when accumbal glutamate 
levels were not markedly elevated by cocaine, drug-seeking behavior was abolished 
(Baker et al., 2003). This suggests that decreasing or counteracting glutamate release 
induced by drug priming or cues decreases drug seeking. 
Supporting this view, cocaine-induced reinstatement can be blocked by accumbal 
AMPA/kainate antagonism or mGluR2/3 agonism (Cornish and Kalivas, 2000; Peters 
and Kalivas, 2006). Similarly, mGluR2/3 agonism suppresses context-induced heroin 
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seeking and cocaine seeking maintained by cues can be decreased by AMPA/kainate 
antagonism (Di Ciano and Everitt, 2001; Bossert et al., 2005). The present results add to 
these findings. Further support for the involvement of glutamate transmission in 
behavior guided by cues comes from a study in which accumbal AMPA/kainate 
antagonism attenuated the sensitized locomotor response to a challenge injection of 
cocaine. This effect was seen only in rats treated repeatedly with cocaine in a specific 
testing environment and not in rats that had received saline or cocaine in the home cage 
without stimulus pairing (Bell et al., 2000). The effects of ionotropic glutamate receptor 
antagonism seem to be specific to drug seeking, as food-seeking behavior is unaffected 
by systemic or intracranial treatments (Bespalov et al., 2005; Sun et al., 2005). 
It is very likely that the rats in the present experiments developed changes in glutamate 
transmission similar to the ones described above following the 7-week drug conditioning 
and self-administration phase and subsequent withdrawal period. Therefore, re-exposure 
to cocaine- and alcohol-associated cues could have triggered drug-seeking behavior 
through increased glutamate release. The glutamate receptor agonists used in the 
experiments may have diminished glutamate release and the antagonists the effects of 
glutamate on postsynaptic cells, thus decreasing drug seeking. However, pretreatment 
with glutamate agonists and antagonists can also have had effects that are relatively 
independent of previous drug exposure. First, the pretreatments can have affected the 
motivation to seek drugs in general. Consistent with this, NMDA, AMPA, and mGluR5 
antagonists have been reported to decrease the motivation to self-administer nicotine, 
cocaine, and alcohol under a progressive ratio schedule of reinforcement (Stephens and 
Brown, 1999; Allen et al., 2005; Paterson and Markou, 2005). Second, the pretreatments 
may have attenuated the ability of drug-associated stimuli to trigger drug-seeking 
behavior. There are several means to this including decreased perception of stimuli, 
decreased ability of stimuli to guide behavior despite intact perception, and decreased 
ability to retrieve the stimulus-reward association meaning that the rats were no longer 
able to associate the stimulus with its conditioned effects.  
Memory retrieval, but not consolidation, is considered to require AMPA receptor 
activation (Izquierdo et al., 1997; Roullet et al., 2001). For example, AMPA/kainate 
antagonism decreases the ability of animals to detect a spatial re-arrangement of objects 
when administered before testing, but not if administered after training (Roullet et al., 
2001). Di Ciano et al. (2001) showed that also discrimination is impaired as rats were 
unable to discriminate between stimuli paired with reward and nonreward after intra-
accumbal infusions of an AMPA/kainate antagonist in a Pavlovian approach behavior 
study. NMDA antagonists, especially channel blockers, have also been shown to decrease 
discriminability and accuracy (Willmore et al., 2001; Gargiulo et al., 2005). Thus, 
decreased memory retrieval or stimulus recognition might explain the effects of the 
ionotropic antagonists used in the present study. For metabotropic agonists, decreased 
choice accuracy has been reported after administration of an mGluR2/3 agonist, LY354740 
(Higgins et al., 2004). On the other hand, mGluR2/3 and mGluR4/6 agonists have been 
reported to enhance memory retrieval (Szapiro et al., 2001).  A broad spectrum 
metabotropic glutamate receptor antagonist, MCPG, was found not to affect cue-guided 
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performance in the Morris water maze, where animals must to find a non-visible platform 
submerged in water with the help of external cues (Bordi et al., 1996). Also MPEP has 
been reported to leave object recognition memory intact in an object novelty preference 
task (Barker et al., 2006) suggesting that it does not affect memory retrieval. 
6.8 Neural pathways mediating drug-seeking behavior 
It has been shown that drug-seeking behavior can be induced by electrical or 
pharmacological stimulation of the prefrontal cortex, amygdala and hippocampus, all of 
which send glutamatergic projections to the nucleus accumbens (McFarland and Kalivas, 
2001; Vorel et al., 2001; Hayes et al., 2003).  Accordingly, inactivation or lesions of 
these structures attenuates cocaine seeking (Meil and See, 1997; McFarland and Kalivas, 
2001; McLaughlin and See, 2003; Sun and Rebec, 2003). So far, at least the amygdala 
and the prefrontal cortex have been implicated as the source of accumbal glutamate 
released in response to drug-associated cues. Infusions of a dopamine antagonist into the 
basolateral amygdala and an AMPA/kainate antagonist into the contralateral nucleus 
accumbens core, neither of which had any effects on its own, abolished cue-induced 
drug seeking under a second-order schedule of self-administration showing that the 
connection from the amygdala to the nucleus accumbens is critically involved (Di Ciano 
and Everitt, 2004). Inactivation of the prefrontal cortex with the GABA agonists 
baclofen and muscimol, on the other hand, blocks cocaine-induced increases in nucleus 
accumbens glutamate levels (McFarland et al., 2003) and cue-induced reinstatement of 
cocaine seeking (Pierce et al., 1998; McLaughlin and See, 2003). In addition, lesions of 
the prefrontal cortex disrupt the ability of cocaine-associated stimuli to guide behavior 
under a second-order schedule of reinforcement (Weissenborn et al., 1997). This 
suggests that in addition to the nucleus accumbens, both the prefrontal cortex and the 
amygdala are involved in the guidance of drug-seeking behavior. 
The core and shell subregions of the accumbens seem to differentially participate in the 
mediation of the effects of glutamate and cues on drug seeking. The injections in the present 
experiments (Study VI) were targeted at the accumbens core, but a possibility of diffusion 
into nearby shell structures cannot be totally ruled out. Manipulations targeting glutamate 
transmission in the accumbens shell have so far been mostly unsuccessful, whereas lesions or 
inactivation of the core impaired responding for cocaine and cocaine seeking under second-
order schedules of reinforcement (Di Ciano and Everitt, 2004; Ito et al., 2004). Also cue-
induced drug seeking can be blocked by GABA agonist-induced inactivation of the 
accumbens core (Fuchs et al., 2004) or by infusions of ionotropic glutamate receptor 
antagonists in the accumbens core, but not shell (Di Ciano and Everitt, 2001).  
This view was recently challenged by Bossert et al. (2005) who found that the mGluR2/3 
agonist LY379268, which acts to decrease presynaptic transmitter release, attenuated 
context-induced heroin seeking when administered into the shell but not core, except at 
very high doses. This may reflect a difference between contextual and discrete cues in 
inducing reinstatement, or, alternatively, the effects of LY379268 could have been 
mediated via decreased dopamine, and not glutamate, release (Kim et al., 2005). 
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Dopamine release has been shown to be enhanced following exposure to cocaine- or 
alcohol-associated discriminative stimuli (Katner and Weiss, 1999; Weiss et al., 2000), 
and cocaine and alcohol reinstatement can be attenuated by systemical dopamine 
antagonism (Crombag et al., 2002; Liu and Weiss, 2002). Therefore, the effects of 
LY379268 and possibly also (S)-3,4-DCPG seen in the alcohol reinstatement study (IV) 
could be due to either decreased glutamate or dopamine release. With regard to 
dopamine, the shell region of the accumbens may be more important than the core as 
reinstatement can be induced by infusing a dopamine agonist into the shell, but not core 
(Schmidt et al., 2006). Also, decreased reinstatement has been reported following 
dopamine antagonist administration into the accumbens shell, whereas administration 
into the core has been ineffective (Anderson et al., 2003; Anderson et al., 2006). 
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7 CONCLUSIONS
1. Drug-seeking behavior, as measured by fixed-interval second-order self-
administration, the alcohol deprivation effect, or cue-induced reinstatement of 
responding, could be attenuated by antagonism at AMPA/kainate, NMDA, and 
metabotropic mGlu5 glutamate receptors. However, NMDA antagonists 
differentially modulated drug seeking with NMDA/glycine antagonism 
decreasing drug seeking and antagonism at the competitive glutamate binging site 
or the uncompetitive channel blocking site being ineffective. In addition, 
metabotropic glutamate receptor agonism at group II/III receptors, which 
presumably decreases postsynaptic glutamate release, attenuated alcohol seeking 
and self-administration. The results suggest that drug-associated cues activate 
glutamatergic neurotransmission and that counteracting the effects of glutamate 
can attenuate the ability of these cues to guide behavior. 
2. Cocaine- and alcohol-seeking behavior induced by drug-associated cues was 
similarly affected by systemically administered glutamate receptor antagonists 
suggesting that glutamate transmission modulates drug seeking across drug 
classes.
3. Accumbal AMPA/kainate, NMDA, and mGluR5 antagonism attenuated cue-
induced drug seeking suggesting that the nucleus accumbens is at least one of the 
anatomical sites where glutamate mediates the effects of cues on behavior. 
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